Annual / Quarterly Financial Statement • Mar 31, 2022
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer





| Corporate bodies _________ |
5 |
|---|---|
| SEPARATE FINANCIAL STATEMENTS AND NOTES THERETO AT 31 DECEMBER 2021 | _____7 |
| STATEMENT OF FINANCIAL POSITION____________ | 9 |
| STATEMENT OF PROFIT OR LOSS__________10 | |
| STATEMENT OF COMPREHENSIVE INCOME________10 | |
| STATEMENT OF CASH FLOWS ____________11 |
|
| STATEMENT OF CHANGES IN EQUITY ____________13 |
|
| NOTES TO THE SEPARATE FINANCIAL STATEMENTS AT 31 DECEMBER 2021 _______14 |
|
| NOTES TO THE STATEMENT OF FINANCIAL POSITION ______35 |
|
| NOTES TO THE STATEMENT OF PROFIT OR LOSS __________68 |
|
| OTHER INFORMATION____________78 | |
| ANNEXES TO THE SEPARATE FINANCIAL STATEMENTS _________91 |
|
| Independent auditors' report ____________92 |



| Chairperson | Luigi Rossi Luciani | |
|---|---|---|
| Executive deputy chairperson | Luigi Nalini | |
| Chief executive officer | Francesco Nalini | |
| Board of directors | Executive director | Carlotta Rossi Luciani |
| Independent director | Cinzia Donalisio | |
| Independent director | Marina Manna | |
| Independent director | Maria Grazia Filippini | |
| Chairperson | Paolo Prandi | |
| Board of statutory auditors | Standing statutory auditor | Saverio Bozzolan |
| Standing statutory auditor | Claudia Civolani | |
| Alternate statutory auditor | Fabio Gallo | |
| Alternate statutory auditor | Alessandra Pederzoli | |
| Independent auditors | Deloitte & Touche SpA | |
| Chairperson | Marina Manna | |
| Control and risks committee | Member | Cinzia Donalisio |
| Member | Maria Grazia Filippini | |
| Chairperson | Cinzia Donalisio | |
| Remuneration committee | Member | Marina Manna |
| Member | Maria Grazia Filippini | |
| Chairperson | Fabio Pinelli | |
| Supervisory body pursuant to Legislative | Member | Arianna Giglio |
| decree no. 231/2001 | Member | Alessandro Grassetto |



at 31 december 2021



| (in Euros) | NOTE | 31.12.2021 | 31.12.2020 |
|---|---|---|---|
| Property, plant and equipment | 1 | 24,534,770 | 25,020,848 |
| Intangible assets | 2 | 11,507,060 | 12,027,142 |
| Equity investments | 3 | 152,979,320 | 117,497,857 |
| Other non-current assets | 4 | 23,396,818 | 9,884,981 |
| Deferred tax assets | 5 | 1,797,572 | 1,771,274 |
| Non-current assets | 214,215,540 | 166,202,102 | |
| Trade receivables | 6 | 48,835,935 | 36,782,785 |
| Inventories | 7 | 25,160,491 | 18,821,530 |
| Current tax assets | 8 | 1,810,801 | 1,552,727 |
| Other current assets | 9 | 5,509,868 | 5,222,898 |
| Current financial assets | 10 | 665,400 | 7,522,254 |
| Cash and cash equivalents | 11 | 53,646,914 | 70,705,564 |
| Total current assets | 135,629,409 | 140,607,758 | |
| TOTAL ASSETS | 349,844,949 | 306,809,860 | |
| Equity | 12 | 106,369,182 | 89,915,930 |
| Equity | 106,369,182 | 89,915,930 | |
| Financial liabilities | 13 | 82,258,056 | 101,994,987 |
| Provisions for risks | 14 | 1,110,101 | 1,042,510 |
| Defined benefit plans | 15 | 4,969,369 | 5,140,774 |
| Deferred tax liabilities | 16 | 197,727 | 241,861 |
| Other non-current liabilities | 17 | 8,057,186 | - |
| Non-current liabilities | 96,592,439 | 108,420,132 | |
| Current financial liabilities | 13 | 78,100,896 | 55,763,973 |
| Trade payables | 18 | 52,400,843 | 37,634,976 |
| Current tax liabilities | 19 | 50,982 | 118,958 |
| Provisions for risks | 14 | 1,907,436 | 2,103,893 |
| Other current liabilities | 20 | 14,423,171 | 12,851,998 |
| Current liabilities | 146,883,328 | 108,473,798 | |
| TOTAL LIABILITIES AND EQUITY | 349,844,949 | 306,809,860 |

| (in Euros) | NOTE | 2021 | 2020 |
|---|---|---|---|
| Revenue | 21 | 215,424,960 | 180,367,359 |
| Other revenue | 22 | 7,448,063 | 4,667,811 |
| Costs of raw materials, consumables and goods and change in inventories |
23 | (114,812,228) | (94,417,153) |
| Services | 24 | (30,130,074) | (26,281,340) |
| Capitalised development expenditure | 25 | 886,991 | 1,856,559 |
| Personnel expense | 26 | (46,500,274) | (42,172,501) |
| Other expense, net | 27 | (764,212) | (538,652) |
| Amortisation, depreciation and impairment losses | 28 | (8,525,156) | (8,244,653) |
| OPERATING PROFIT | 23,028,070 | 15,237,430 | |
| Net financial income | 29 | 7,798,965 | 13,900,532 |
| Net exchange gains (losses) | 30 | 147,317 | (428,062) |
| Net impairment gains (losses) on financial assets | 31 | 957,003 | (3,284,372) |
| PROFIT BEFORE TAX | 31,931,355 | 25,425,528 | |
| Income taxes | 32 | (4,612,908) | (4,529,610) |
| PROFIT FOR THE YEAR | 27,318,447 | 20,895,918 |
| (in Euros) | NOTE | 2021 | 2020 |
|---|---|---|---|
| PROFIT FOR THE YEAR | 27,318,447 | 20,895,918 | |
| Other items that may be subsequently reclassified to profit or loss: |
|||
| Variation in hedging reserve | 12 | 506,104 | (96,130) |
| Variation in hedging reserve - tax effect | 12 | (121,465) | 23,071 |
| Total items that may be subsequently reclassified to profit or loss |
384,639 | (73,059) | |
| Other items that may not be subsequently reclassified to profit or loss: |
|||
| IAS 19 - Actuarial gains (losses) on post-employment benefits | 12 | (95,145) | (76,156) |
| IAS 19 - Actuarial gains (losses) on post-employment benefits - tax effect |
12 | 26,546 | 21,247 |
| IAS 19 - Actuarial gains (losses) on post-term of office benefits for directors |
12 | (11,767) | 23,556 |
| IAS 19 - Actuarial gains (losses) on post-term of office benefits for directors - tax effect |
12 | - | (39,598) |
| Total other items that may not be subsequently reclassified to profit or loss |
(80,366) | (70,951) | |
| COMPREHENSIVE INCOME | 27,622,720 | 20,751,908 |


| (in Euros) | 2021 | 2020 |
|---|---|---|
| Profit for the year | 27,318,447 | 20,895,918 |
| Adjustments for: | ||
| Amortisation, depreciation and impairment losses | 7,568,153 | 11,529,025 |
| Accruals to provisions | 2,450,999 | 1,706,965 |
| Non-monetary financial income | (8,245,116) | (13,998,823) |
| Income taxes | 2,396,308 | 3,268,767 |
| Gains on the sale of non-current assets | (70,918) | (1,505) |
| 31,417,873 | 23,400,347 | |
| Changes in working capital: | ||
| Change in trade receivables and other current assets | (11,638,822) | (517,127) |
| Change in inventories | (6,819,446) | (942,584) |
| Change in trade payables and other current liabilities | 14,864,380 | 9,827,478 |
| Change in non-current assets | 89,524 | - |
| Change in non-current liabilities | (430,027) | (394,171) |
| Cash flows from operating activities | 27,483,482 | 31,373,943 |
| Net interest paid | (1,097,639) | (978,052) |
| Income taxes paid | (2,323,199) | (3,536,632) |
| Net cash flows from operating activities | 24,062,644 | 26,859,259 |
| Investments in property, plant and equipment | (4,388,076) | (3,760,667) |
| Investments in intangible assets | (3,370,153) | (4,226,321) |
| Disinvestments of property, plant and equipment and intangible assets | 306,775 | 98,685 |
| Investments in investees | (25,099,722) | (15,000) |
| Cash flows used in investing activities | (32,551,176) | (7,903,303) |
| Repurchase of treasury shares | - | (957,622) |
| Dividend distributions | (11,987,937) | (11,979,815) |
| Dividends collected | 9,139,818 | 14,944,286 |
| Interest collected | 143,848 | 41,802 |
| Increase in financial liabilities | 66,913,198 | 74,022,395 |
| Decrease in financial liabilities | (63,702,382) | (44,971,375) |
| Decrease in lease liabilities | (1,615,411) | (1,446,634) |
| Increase in financial assets | (14,982,894) | (7,500,023) |
| Decrease in financial assets | 7,521,642 | 4,011,208 |
| Cash flows from (used in) financing activities | (8,570,118) | 26,164,222 |
| Change in cash and cash equivalents | (17,058,650) | 45,120,178 |
| Cash and cash equivalents - opening balance | 70,705,564 | 25,585,386 |
| Cash and cash equivalents - closing balance | 53,646,914 | 70,705,564 |

| (in Euros) | Share capital | Legal reserve | Hedging reserve | Actuarial reserve | |
|---|---|---|---|---|---|
| Balance at 31 December 2019 | 10,000,000 | 2,000,000 | (362,698) | (220,397) | |
| Allocation of prior year profit | |||||
| - dividend distributions | |||||
| - other allocations | |||||
| Movements in stock grant reserve | |||||
| Repurchase of treasury shares | |||||
| Profit for the year | |||||
| Other comprehensive expense | (73,059) | (70,951) | |||
| 31 December 2020 | 10,000,000 | 2,000,000 | (435,757) | (291,348) | |
| Allocation of prior year profit | |||||
| - dividend distributions | |||||
| - other allocations | |||||
| Movements in stock grant reserve | |||||
| Repurchase of treasury shares | |||||
| Assignment of treasury shares | |||||
| Profit for the year | |||||
| Other comprehensive income | 384,639 | (80,366) | |||
| 31 December 2021 | 10,000,000 | 2,000,000 | (51,118) | (371,714) |


STATEMENT OF CHANGES IN EQUITY
| Total | Profit for the year |
Retained earnings |
Stock grant reserve |
Treasury shares |
IFRS reserve | Equity-related reserves |
Income-related reserves and other reserves |
|---|---|---|---|---|---|---|---|
| 81,334,813 | 22,708,460 | 476,149 | 417,469 | (807,278) | 2,145,495 | 10,397,335 | 34,580,278 |
| (11,979,815) | (11,979,815) | ||||||
| - | (10,728,645) | 10,728,645 | |||||
| 766,646 | 766,646 | ||||||
| (957,622) | (957,622) | ||||||
| 20,895,918 | 20,895,918 | ||||||
| (144,010) | - | - | |||||
| 89,915,930 | 20,895,918 | 476,149 | 1,184,115 | (1,764,900) | 2,145,495 | 10,397,335 | 45,308,923 |
| (11,987,938) | (11,979,815) | (8,123) | |||||
| - | (8,916,103) | (34,085) | 8,950,188 | ||||
| 161,440 | 161,440 | ||||||
| 657,030 | 657,030 | ||||||
| 27,318,447 | 27,318,447 | ||||||
| 304,273 | - | - | |||||
| 106,369,182 | 27,318,447 | 476,149 | 1,311,470 | (1,107,870) | 2,145,495 | 10,397,335 | 54,250,988 |

Carel Industries S.p.A. (the "company") is an Italian company limited by shares, with registered office in Via Dell'Industria 11, Brugine (PD). It is registered with the Padua company registrar.
Carel Industries S.p.A. provides control instruments to the air-conditioning and commercial and industrial refrigeration markets and also produces air humidification systems.
These separate financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) and cover the year from 1 January to 31 December 2021.
The company has prepared its separate and consolidated financial statements in accordance with the IFRS endorsed by the European Union on 1 January 2015 (the transition date).
The company's board of directors approved the separate financial statements at 31 December 2021 on 3 March 2022.
The separate financial statements have been prepared in accordance with the updated accounting records.
The separate financial statements at 31 December 2021 were prepared in accordance with the IFRS issued by the International Accounting Standards Board (IASB) and endorsed by the European Commission with the procedure set out in article 6 of Regulation (EC) no. 1606/2002 of the European Parliament and of the Council of 19 July 2002.
The IFRS include all the standards as well as the interpretations of the International Financial Reporting Standards Interpretations Committee (IFRS IC), previously called the Standing Interpretations Committee (SIC), endorsed by the European Union at the reporting date and included in the related EU regulations published at that date.
The separate financial statements include the statement of financial position, statement of profit or loss, statement of comprehensive income, statement of changes in equity, statement of cash flows and these notes. They were prepared using the historical cost principle and assuming the company will continue as a going concern. The company assumed that it could adopt the going concern assumption pursuant to IAS 1.25/26 given its strong market position, very satisfactory profits and solid financial structure.
The separate financial statements were prepared in Euros, which is the company's functional and presentation currency as per IAS 21, unless indicated otherwise.
The company availed itself of the option allowed by article 40.2-bis of Legislative decree no. 127 of 9 April 1991, as amended by Legislative decree no. 32 of 2 February 2007, which provides for the preparation of a single directors' report for the separate and consolidated financial statements of Carel Industries S.p.A.


Statement of financial position. Assets and liabilities are presented as current or non-current as required by paragraph 60 and following paragraphs of IAS 1.
An asset or liability is classified as current when it meets one of the following criteria:
All other assets and liabilities are classified as non-current.
Statement of profit or loss. The company has opted to present the statement of profit or loss classifying items by their nature rather than their function, as this best represents the transactions undertaken during the year and its business structure. This approach is consistent with the company's internal management reporting system and international best practices for its sector. Following adoption of revised IAS 1, the company decided to present the statement of profit or loss and other comprehensive income in two separate statements.
Statement of comprehensive income. This statement, prepared in accordance with the IFRS, presents other items of comprehensive income that are recognised directly in equity.
Statement of cash flows. The company prepares this statement using the indirect method. Cash and cash equivalents included herein comprise the statement of financial position balances at the reporting date. Interest income and expense and income taxes are included in the cash flows from operating activities, except for interest accrued on available-for-sale financial assets and dividends received, which are presented under cash flows from financing activities. The company presents cash flows from operating activities, and investing activities and changes in non-current financial position, current liabilities and current financial assets separately. If not specified, exchange gains and losses are classified in the operating activities as they refer to the translation of trade receivables and payables into Euros.
Statement of changes in equity. This statement shows changes in the equity captions related to:

Business combinations are treated using the acquisition method. The consideration is recognised at fair value, calculated as the sum of the acquisition-date fair values of the assets transferred and liabilities assumed by the acquirer and the equity interests issued in exchange for control of the acquiree. Transaction costs are usually recognised in profit or loss when they are incurred.
The assets acquired and the liabilities assumed are recognised at their acquisition-date fair value, except for the following items which are measured in line with the relevant IFRS:
Goodwill is calculated as the excess of the aggregate of the consideration transferred for a business combination, the amount of any non-controlling interest in the acquiree and the acquisition-date fair value of the acquirer's previously held equity interest in the acquiree and the net of the acquisition-date fair value of the assets acquired and liabilities assumed. Goodwill is only recognised after its recoverability has been tested by analysing its future cash flows.
If the acquisition-date fair value of the assets acquired and liabilities assumed is greater than the consideration transferred, the amount of any non-controlling interest in the acquiree and the acquisition-date fair value of the acquirer's previously held equity interest in the acquiree, the resulting gain is recognised immediately in profit or loss.
The amount of any non-controlling interest in the acquiree at the acquisition date is the pre-combination carrying amount of the acquiree's net assets.
Contingent consideration is measured at its acquisition-date fair value and included in the consideration exchanged for the acquiree to calculate goodwill. Any subsequent changes in fair value, which are measurement period adjustments, are included in goodwill retrospectively. Changes in fair value which are measurement period adjustments are those that arise due to additional information becoming available about facts and circumstances that existed at the acquisition date and was obtained during the measurement period (that cannot exceed one year from the acquisition date). Any subsequent change in contingent consideration is included in profit or loss.
The separate financial statements at 31 December 2021 were prepared in accordance with the IFRS issued by the IASB, endorsed by the European Commission and applicable at the reporting date. They are presented in Euros, which is the company's functional currency, i.e., the currency of the primary economic environment in which it mainly operates. Amounts are rounded to the nearest unit.
The separate financial statements at 31 December 2021 present the company's financial position and performance, in accordance with the IFRS.
They were prepared using the historical cost criterion, except for derivative financial instruments hedging currency and interest rate risks and available-for-sale financial assets, which were measured at fair value as required by IFRS 9 Financial instruments: recognition and measurement.
Preparation of separate financial statements under the IFRS requires management to make estimates and assumptions that affect the amounts in the financial statements and the notes. Actual results may differ from these estimates. Reference should be made to the "Use of estimates" section for details of the captions more

likely to be affected by estimates.
Following its decision to adopt the IFRS starting from the separate financial statements at 31 December 2017, the company referred to the standards applicable from 1 January 2017 to prepare its separate financial statements at 31 December 2021, in accordance with the provisions of IFRS 1.
The company applied the following standards, amendments and interpretations for the first time starting from 1 January 2021:
All of these amendments became effective on 1 January 2021. Their adoption did not significantly affect the separate financial statements.
These amendments become effective on 1 January 2022. The directors do not expect these amendments to significantly affect the company's separate financial statements.

At the reporting date, the EU's relevant bodies had not yet completed the endorsement process for adoption of the following amendments and standards.
Revenue is measured based on the fee contractually-agreed with the customer and does not include amounts collected on behalf of third parties. The company recognises revenue when control of the goods or services is transferred to the customer. Revenue is recognised to the extent it is probable the company will receive the economic benefits and it can be measured reliably. Most contracts with customers provide for commercial discounts and discounts based on volumes, which modify the revenue itself. In defining the amount of the variable consideration that may be included in the transaction price, the company calculates the amount of variable considerations that cannot yet be considered realised at each reporting date.
Revenue from the sale of HVAC products and services refer to sales of products for air control and humidification in the industrial, residential and commercial segment (heat ventilation and air conditioning), while refrigeration revenue refers to sales to the food retail and food service segment. The sales in both markets can be divided into the following three macro channels: (i) OEM (Original Equipment Manufacturers), (ii) Dealers and (iii) Projects. Non-core revenue is earned on products that do not make up the company's core business.
The warranties related to these categories of products are warranties for general repair and in most cases, the company does not provide such warranties. The company recognises warranties in compliance with IAS 37 Provisions, contingent liabilities and contingent assets.
There are no significant services provided for a lengthy period of time.
Advertising and research costs are expensed in full as required by IAS 38 Intangible assets. Revenue from services is recognised when the services are rendered.


Revenue and expenses are recognised on an accruals basis in line with the interest accrued on the carrying amount of the related financial assets and liabilities using the effective interest method.
They are recognised when the shareholder's right to receive payment is established, which normally takes place when the shareholders pass the related resolution. The dividend distribution is recognised as a liability in the financial statements of the period in which the shareholders approve such distribution.
They reflect a realistic estimate of the company's tax burden, calculated in accordance with the current regulations; current tax liabilities are recognised in the statement of financial position net of any payments on account.
Deferred tax assets and liabilities arise on temporary differences between the carrying amount of an asset or liability pursuant to the IFRS and its tax base, calculated using the tax rates reasonably expected to be enacted in future years. Deferred tax assets are only recognised when their recovery is probable while deferred tax liabilities are always recognised as required by IAS 12 Income taxes. The company does not apply any netting of current and deferred taxes. Deferred tax liabilities on untaxed reserves are accounted for in the year in which the liability to pay the dividend is recognised.
Income taxes relative to prior years include prior year tax income and expense.
Foreign currency receivables and payables are translated into Euros using the transaction-date exchange rate. Any gains or losses when the foreign currency receivable is collected or the payable settled are recognised in profit or loss.
Revenue, income, costs and expenses related to foreign currency transactions are recognised at the spot rate ruling on the transaction date. At the closing date, foreign currency assets and liabilities are retranslated using the spot closing rate and the related exchange rate gains or losses are recognised in profit or loss. Nonmonetary items are recognised using the transaction-date exchange rate.
They are recognised at historical cost, including ancillary costs necessary to ready the asset for the use for which it has been purchased.
Maintenance and repair costs that do not extend the asset's life and/or enhance its value are expensed when incurred; otherwise, they are capitalised.
Property, plant and equipment are stated net of accumulated depreciation and impairment losses calculated using the methods described later in this section. The depreciable amount of an asset is allocated on a systematic basis over its useful life, which is reviewed once a year. Any necessary changes are applied prospectively.

| Category of assets | Aliquote % |
|---|---|
| Buildings: | |
| - Light constructions | 10.00% |
| - Industrial buildings | 3.00% |
| Plant and machinery: | |
| - Generic plant | 10.00% |
| - Automatic operating machinery | 10.00%-15.50% |
| Industrial and commercial equipment | 25.00% |
| Other items of property, plant and equipment: | |
| - Office furniture and equipment | 12.00%-20.00% |
| - Hardware | 20.00% |
| - Cars | 25.00% |
| - Telecommunication systems | 20.00% |
| - Other items of property, plant and equipment | 20.00% |
| - Right-of-use assets | Contract term |
Land has an indefinite useful life and therefore is not depreciated.
Assets held under lease are recognised as right-of-use assets at the present value of the lease payments.
The liability to the lessor is shown under financial liabilities. The leased assets are depreciated over the lease term.
Lease payments for short-term leases or leases of low-value assets are recognised in profit or loss over the lease term.
When the asset is sold or there are no future economic benefits expected from its use, it is derecognised and the gain or loss (calculated as the difference between the asset's sales price and carrying amount) is recognised in profit or loss in the year of derecognition.
Leasehold improvements that are not economically separable from the assets in use are depreciated over the useful life of the costs incurred, from the moment they are incurred or when the asset become available for use.
These are identifiable, non-monetary assets without physical substance that are controlled by the entity and from which future economic benefits are expected to flow to the entity. They are initially recognised at cost when this can be reliably determined using the same methods applied to property, plant and equipment.
These assets are subsequently presented net of accumulated amortisation and any impairment losses. Their useful life is reviewed regularly and any changes are applied prospectively. Costs incurred to internally generate an intangible asset are capitalised in line with the provisions of IAS 38.
Their estimated average useful life is between three and ten years.
Gains or losses on the sale of an intangible asset are calculated as the difference between the asset's sales price and its carrying amount. They are recognised in profit or loss at the sales date.


This is the excess cost of the aggregate of the consideration transferred for a business combination, the amount of any non-controlling interest in the acquiree and the acquisition-date fair value of the acquirer's previously held equity interest in the acquiree over the net of the acquisition-date amounts of the assets acquired and liabilities assumed. Goodwill is not amortised but is tested annually for impairment or whenever a trigger event occurs. For the purposes of impairment testing, goodwill is allocated to each of the company's cash-generating units that is expected to benefit from the business combination.
This is for the development of new products and the improvement of existing products and for the development and improvement of production processes. It is capitalised in accordance with IAS 38 if the innovations introduced create processes that are technically feasible and/or marketable products provided that they are aimed at completing development projects and the resources necessary for the completion and the costs and economic benefits of such innovations can be reliably measured. The expenses that are capitalised include internal and external design costs (including personnel expense and the cost of the services and materials used) reasonably attributable to the projects. As development expenditure is an intangible asset with a finite useful life, it is amortised in line with the period in which the economic benefits are expected to be obtained, generally identified as five years. The expenses are adjusted for impairment losses that could occur after first recognition. Amortisation begins from the moment that the products become available for use. The useful life is reviewed and adjusted in line with the expected future use.
Assets with an indefinite useful life are not amortised but are tested for impairment once a year to check whether their carrying amount has undergone impairment.
The board of directors adopted a policy that defines the criteria for the impairment test, the controls to be carried out to guarantee the reliability of the process and the procedure to approve the test, in line with Consob recommendation no. 0003907 of 15 January 2015.
Amortisable assets are tested for impairment whenever events or circumstances suggest that their carrying amount cannot be recovered (trigger events). In both cases, the impairment loss is the amount by which the asset's carrying amount exceeds its recoverable amount, which is the higher of the asset's fair value less costs to sell and its value in use. If it is not possible to determine an asset's value in use, the recoverable value of the cash-generating unit (CGU) to which the asset belongs is calculated. Assets are grouped into the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. The company calculates the present value of the estimated future cash flows of the CGU using a discount rate that reflects the time value of money and the risks specific to the asset.
If an impairment loss on an asset other than goodwill subsequently decreases or no longer exists, the carrying amount of the asset or the CGU is increased to the new estimate of its recoverable amount which will not, in any case, exceed the carrying amount the asset would have had if no impairment loss had been recognised.
Reversals of impairment losses are recognised immediately in profit or loss using the model provided for in IAS 16 Property, plant and equipment.

Investments in subsidiaries and associates are recognised as financial assets based on the acquisition cost criterion, including ancillary costs and are adjusted for impairment in accordance with IAS 36. Specifically, if there are indicators of potential impairment losses, an impairment test is carried out.
The carrying amount is adjusted for impairment, the effect of which is recognised in profit or loss as a reduction of the asset. If these losses no longer exist or they decrease, the carrying amount is increased in line with the new recoverable amount, which must not exceed the original cost. The reversal of impairment is recognised in profit or loss.
The company has a call option for the non-controlling interest in one of its investees. It has, therefore, included the fair value of this option in the equity investment's carrying amount, as required by the IFRS.
They are initially recognised at their fair value and subsequently measured at amortised cost. Financial assets are initially recognised at their fair value increased, in the case of assets other than those recognised at fair value through profit or loss, by ancillary costs. When subscribed, the company assesses whether a contract includes embedded derivatives. The embedded derivatives are separated from the host contract if this is not measured at fair value when the analysis shows that the economic characteristics and risks of the embedded derivative are not closely related to those of the host contract.
The company classifies its financial assets after initial recognition and, when appropriate and permitted, reviews this classification at the reporting date.
It recognises all purchases and sales of financial assets at the transaction date, i.e., the date on which the company assumes the commitment to buy the asset.
All financial assets within the scope of IFRS 9 are recognised at amortised cost or fair value depending on the business model for managing the financial asset and the asset's contractual cash flow characteristics. Specifically:
When a debt instrument measured at FVTOCI is derecognised, the cumulative gain or loss previously recognised in other comprehensive income is reclassified from equity to profit or loss as a reclassification adjustment. On the other hand, when an equity instrument measured at FVTOCI is derecognised, the cumulative gain or loss that was previously recognised in other comprehensive income is transferred to retained earnings, without affecting profit or loss.
Debt instruments subsequently measured at amortised cost or FVTOCI are tested for impairment.
Any impairment losses are recognised in profit or loss after use of the fair value reserve if this has been set up. Subsequent reversals of impairment losses are recognised in profit or loss except in the case of equity instruments for which the reversal is recognised in equity.
The company has zero-balance cash pooling contracts with certain European group companies. These


instruments are intended to ensure optimal management of cash flows, allowing for the centralised management of the group's financial needs by transferring to a pooler, namely Carel Industries S.p.A., the credit and debit balances of current accounts of the individual group companies. The main aim is to use the cash surplus of one or more group companies to eliminate or reduce the debt exposure of the other companies. Following the transfer of the balances to the pool account, the individual companies must recognise a liability in the case of a negative balance and an asset in the case of a positive balance. Subsequently, the pooler recognises the individual transactions, sending a statement to the group companies on a regular basis. At the agreed expiry, the pooler manages the payment of the assets/liabilities.
The companies that take part in the cash pooling scheme are: CAREL INDUSTRIES S.p.A. (pooler) and its subsidiaries Carel U.K. Ltd, Carel France s.a.s., Carel Deutschland GmbH, Carel Control Iberica Sl; Carel Adriatic D.o.o., Alfaco Polska Sp.z.o.o, HygroMatik GmbH and Recuperator S.p.A.
They are measured at the lower of purchase and/or production cost, calculated using the weighted average cost method, and net realisable value. Purchase cost comprises all ancillary costs. Production cost includes the directly related costs and a portion of the indirect costs that are reasonably attributable to the products.
Work in progress is measured at average cost considering the stage of completion of the related contracts.
Obsolete and/or slow moving items are written down to reflect their estimated possible use or realisation through an allowance.
The write-down is reversed in subsequent years if the reasons therefor no longer exist.
They are initially recognised at fair value, which is the same as their nominal amount, and subsequently measured at amortised cost and impaired, if appropriate. Their carrying amount is adjusted to their estimated realisable amount through the loss allowance.
Foreign currency trade receivables are translated into Euros using the transaction-date exchange rate and subsequently retranslated using the closing rate. The exchange gain or loss is recognised in profit or loss.
They include cash, i.e., highly liquid investments (maturity of less than three months) that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value.
This caption includes the Italian post-employment benefits ("TFR") and other employee benefits covered by IAS 19 Employee benefits. As a defined benefit plan, independent actuaries calculate the TFR at the end of each reporting period. The liability recognised in the statement of financial position is the present value of the defined benefit obligation at the end of the reporting period. These benefits are calculated using the projected unit credit method. Law no. 296/06 changed the Italian post-employment benefits scheme and benefits accrued after 1 January 2007 are now classified as defined contribution plans (using the terminology provided in IAS 19), regardless of whether the employee decides to have them transferred to the INPS (the Italian social

security institution) treasury fund or an external pension plan. Benefits vested up until 31 December 2006 continue to be recognised as part of a defined benefit plan and are subject to actuarial valuation, excluding the future salary increase component. The company does not have plan assets. It recognises actuarial gains and losses in the period in which they arise. Pursuant to IAS 19 (revised), they have been recognised directly in other comprehensive income starting from 2015.
As required by IAS 37 Provisions, contingent liabilities and contingent assets, the company recognises a provision when (i) it has a present legal or constructive obligation to third parties as a result of a past event, (ii) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and (iii) a reliable estimate can be made of the amount of the obligation. Changes in estimates from one period to another are recognised in profit or loss.
Where the effect of the time value of money is material and the payment dates of the obligation can be estimated reliably, the amount of a provision is the present value of the expenditures expected to be required to settle the obligation. Any subsequent changes arising from the passage of time are recognised as financial income or expense in the statement of profit or loss.
No provision is made for possible but not probable risks but the company provides adequate disclosure thereon in the notes.
Trade payables and other current liabilities which fall due within normal trading terms are initially recognised at cost, which equals their nominal amount, and are not discounted. When their due date is longer than normal trading terms, the interest is separated using an appropriate market rate.
They are classified as current liabilities unless the company has an unconditional right to defer their payment for at least 12 months after the reporting date. The company removes the financial liability when it is extinguished and the company has transferred all the risks and rewards related thereto. Financial liabilities are initially recognised at their fair value and subsequently measured using the amortised cost method.
This caption mainly includes the liability for the call option for a non-controlling interest. The call option was initially measured at its fair value at the acquisition date and it is remeasured at each reporting date. Any resulting fair value gains or losses are recognised in profit or loss under financial income or expense.
The other non-current liabilities are initially recognised at cost, which is equal to their nominal amount.
The company solely uses derivatives to hedge currency risk on foreign currency commercial transactions and interest risk on its medium to long-term debt.
Initial recognition and subsequent measurement is at the derivatives' fair value, applying the following accounting treatments:
Fair value hedge - if a derivative is designated as a hedge of the company's exposure to changes in fair value of a recognised asset or liability that could affect profit or loss, the gain or loss from remeasuring the hedging


instrument at fair value is recognised in profit or loss as is the gain or loss on the hedged item.
Cash flow hedge - if a derivative is designated as a hedge of the exposure to variability in cash flows of a recognised asset or liability or a highly probable forecast transaction that could affect profit or loss, the portion of the gain or loss on the hedging instrument that is determined to be an effective hedge is recognised in other comprehensive income; the cumulative gain or loss is reclassified to profit or loss in the same period during which the hedged forecast cash flows affect profit or loss; the gain or loss on the hedge or the ineffective portion of the gain or loss on the hedging instrument is recognised in profit or loss.
When the conditions for application of hedge accounting are no longer met, the company reclassifies the fair value gains or losses on the derivative directly to profit or loss.
Preparation of the separate financial statements requires management to apply accounting policies and methods that, in certain circumstances, are based on complex and subjective judgements, past experience or assumptions that are considered reliable and realistic at that time depending on the related circumstances. Application of these estimates and assumptions affects the amounts recognised in the statement of financial position, the statement or profit or loss and the statement of cash flows as well as the disclosures. Actual results may differ from those presented in the separate financial statements due to the uncertainty underlying the assumptions and the conditions on which the estimates were based. As detailed later on, the estimates took into consideration the uncertainties generated by the ongoing Covid-19 pandemic, also beyond the reporting date.
The captions that require the greater use of estimates and for which a change in the conditions underlying the assumptions may affect the separate financial statements are:

If there are any internal or external factors that may indicate an impairment loss, the company tests property, plant and equipment, intangible assets and equity investments for impairment. Goodwill is tested for impairment at least once a year, regardless of the occurrence of any trigger events. The company calculates the recoverable amount of the CGU as the value in use using the discounted cash flow method applying assumptions, such as estimates of future increases in sales, operating costs, the growth rate of the terminal value, investments, changes in working capital and the weighted average cost of capital (discount rate).
The value in use may change if the main estimates and assumptions made in the plan change and, hence, the impairment test. Therefore, the realisable value of the recognised assets may also change.
The impairment test took into consideration the effects of the Covid-19 pandemic, especially with regard to forecast cash flows which were estimated using the information available to the directors regarding market conditions and the prospects of recovery from the crisis.
IFRS 13 is the only reference source for fair value measurement and the related disclosures when this measurement is required or permitted by another standard. IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. This standard replaces and extends the disclosure required about fair value measurement in other standards, including IFRS 7 Financial instruments: disclosures.
IFRS 13 establishes a fair value hierarchy that categorises into three levels the inputs to valuation techniques used to measure fair value in hierarchical order as follows:
The method used to estimate fair value is as follows:
The fair value of financial instruments not quoted on an active market is calculated in accordance with valuation techniques generally adopted by the financial sector and specifically:


• reference should be made to note [10] for information on the fair value of the short-term investments.
Reference should be made to the specific comments provided in the notes to the assets or liabilities for more information about the assumptions used to determine fair value.
The objective of IFRS 7 is to require entities to provide disclosures in their financial statements that enable users to evaluate:
The principles in this standard complement the principles for recognising, measuring and presenting financial assets and financial liabilities in IAS 32 Financial instruments: presentation and IFRS 9 Financial instruments: recognition and measurement.
This section presents the supplementary disclosures required by IFRS 7.
The accounting policies applied to measure financial instruments are described in the section on the Accounting policies.
The company's operations expose it to a number of financial risks that can affect its financial position, financial performance and cash flows due to the impact of its financial instruments.
These risks include:
The company's board of directors has overall responsibility for the design and monitoring of a financial risk management system. It is assisted by the various departments involved in the operations generating the different types of risk.
The units establish tools and techniques to protect the company against the above risks and/or transfer them to third parties (through insurance policies) and they assess the risks that are neither hedged nor insured pursuant to the guidelines established by the board of directors for each specific risk.
The degree of the company's exposure to the different financial risk categories is set out below.

The company operates on various national markets with a high number of medium and large-sized customers, mostly regional or local distributors. Therefore, it is exposed to credit risk in conjunction with its customers' ability to generate adequate cash flow.
The company's credit risk management policy includes rating its customers, setting purchase limits and taking legal action. It prepares periodic reports to ensure tight control over credit collection.
The company has a credit manager in charge of credit collection on sales made in their markets. Group companies active in the same market (e.g., the Italian companies) exchange information about common customers electronically and coordinate delivery blocks or the commencement of legal action.
The allowance for doubtful accounts is equal to the nominal amount of the uncollectible receivables after deducting the part of the receivables secured with bank collateral. The company analyses all the collateral given to check collectability. Impairment losses are recognised considering past due receivables from customers with financial difficulties and receivables for which legal action has commenced.
The directors did not detect a deterioration in credit quality or collection times due to the spread of Covid-19, as can be seen in the breakdown below. Furthermore, the company did not modify payment terms applied to customers or its credit risk management policies, while it prudently reinforced monitoring of credit positions with customers.
The following table provides a breakdown of trade receivables and related allowance for doubtful accounts by ageing bracket:
| 31.12.2021 | 31.12.2020 | ||||
|---|---|---|---|---|---|
| (in Euros) | Trade receivables | Allowance | Trade receivables | Allowance | |
| Not yet due | 47,306,832 | (436,117) | 35,405,508 | (111,791) | |
| Past due < 6 months | 1,643,260 | (56,097) | 1,214,514 | (3,957) | |
| Past due > 6 months and < 12 months | 497,071 | (119,014) | 303,559 | (25,048) | |
| Past due > 12 months | 86,948 | (86,948) | 331,121 | (331,121) | |
| Total | 49,534,111 | (698,176) | 37,254,702 | (471,917) |
The company has a high level of liquidity and limited net financial debt. During the year, the company had easy access to additional funding, without additional costs. The company has shown itself to be consistently profitable and able to generate significant liquidity. Therefore, it is not believed that liquidity risk was increased by the pandemic.
The company mainly deals with well-known and reputable customers. Its policy is to submit to assignment procedures and costantly monitor those customers that request payment extensions.


As required by IFRS 7, the next table shows the cash flows of the company's financial liabilities by maturity:
| (in Euros) | |||||
|---|---|---|---|---|---|
| 31.12.2021 | TOTAL | Total cash flows |
Within one year |
From one to five years |
After five years |
| - Non-current bank loans and borrowings at amortised cost |
67,920,086 | 68,374,540 | - | 68,374,540 | - |
| - Non-current lease liabilities | 12,108,309 | 12,405,239 | - | 4,939,399 | 7,465,840 |
| - Effective designated derivative hedges | 108,401 | 108,401 | - | 108,401 | - |
| - Other non-current loans and borrowings at amortised cost |
681,246 | 692,355 | - | 692,355 | - |
| - Other non-current financial liabilities | 1,440,014 | 1,440,014 | - | 1,000,000 | 440,014 |
| Non-current financial liabilities | 82,258,056 | 83,020,549 | - | 75,114,695 | 7,905,854 |
| - Current portion of bank loans at amortised cost |
60,196,202 | 60,531,973 | 60,531,973 | - | - |
| - Current lease liabilities | 1,310,656 | 1,385,118 | 1,385,118 | ||
| - Other current loans and borrowings at amortised cost |
191,170 | 197,816 | 197,816 | - | - |
| - Derivatives held for trading at fair value through profit or loss |
40,625 | 40,625 | 40,625 | - | - |
| - Financial liabilities with group companies |
16,343,510 | 16,367,526 | 16,367,526 | - | - |
| - Other current financial liabilities | 18,733 | 18,733 | 18,733 | - | - |
| Current financial liabilities | 78,100,896 | 78,541,791 | 78,541,791 | - | - |
| 31.12.2020 | TOTAL | Total cash flows |
Within one year |
From one to five years |
After five years |
|---|---|---|---|---|---|
| - Non-current bank loans and borrowings at amortised cost |
86,908,727 | 87,593,024 | - | 87,593,024 | - |
| - Non-current lease liabilities | 13,635,510 | 14,040,611 | - | 4,941,958 | 9,098,653 |
| - Effective designated derivative hedges | 578,334 | 578,334 | - | 578,334 | - |
| - Other non-current loans and borrowings at amortised cost |
872,416 | 890,172 | - | 791,264 | 98,908 |
| Non-current financial liabilities | 101,994,987 | 103,102,141 | - | 93,904,580 | 9,197,561 |
| - Current portion of bank loans at amortised cost |
42,462,870 | 42,946,044 | 42,946,044 | - | - |
| - Current lease liabilities | 1,351,377 | 1,405,679 | 1,405,679 | ||
| - Other current loans and borrowings at amortised cost |
314,653 | 323,131 | 323,131 | - | - |
| - Derivatives held for trading at fair value through profit or loss |
2,744 | 2,744 | 2,744 | - | - |
| - Financial liabilities with group companies |
11,632,329 | 11,632,329 | 11,632,329 | - | - |
| Current financial liabilities | 55,763,973 | 56,309,927 | 56,309,927 | - | - |

The next table shows the categorisation of financial assets and liabilities at the reporting date in accordance with IFRS 9 and their fair value:
| (in Euros) | Fair value | ||||
|---|---|---|---|---|---|
| 31.12.2021 | IFRS 9 category | Carrying amount |
Level 1 | Level 2 | Level 3 |
| Intragroup financial assets | Loans and receivables | 14,404,493 | 14,404,493 | ||
| Derivatives | Financial instruments held for trading |
81,766 | 81,766 | ||
| Other non-current financial assets |
14,486,259 | ||||
| Derivatives | Financial instruments held for trading |
4,621 | 4,621 | ||
| Intragroup financial assets | Loans and receivables | 660,779 | 660,779 | ||
| Other current financial assets | 665,400 | ||||
| Trade receivables | Loans and receivables | 48,835,935 | 48,835,935 | ||
| Total financial assets | 63,987,594 | ||||
| including: | Financial instruments held for trading |
86,387 | - | 86,387 | - |
| Loans and receivables | 63,901,207 | - | - | 63,901,207 | |
| Bank loans and borrowings | Financial liabilities at amortised cost |
(67,920,086) | (67,920,086) | ||
| Other loans and borrowings | Financial liabilities at amortised cost |
(2,121,260) | (681,246) | (1,440,014) | |
| Non-current lease liabilities | Financial liabilities at amortised cost |
(12,108,309) | (12,108,309) | ||
| Effective derivatives | Derivatives | (108,401) | (108,401) | ||
| Non-current financial liabilities | (82,258,056) | ||||
| Current bank loans | Financial liabilities at amortised cost |
(60,196,202) | (60,196,202) | ||
| Other loans and borrowings | Financial liabilities at amortised cost |
(209,903) | (191,170) | (18,733) | |
| Current lease liabilities | Financial liabilities at amortised cost |
(1,310,656) | (1,310,656) | ||
| Effective derivatives | Derivatives | (40,625) | (40,625) | ||
| Financial liabilities with group companies |
Financial liabilities at amortised cost |
(16,343,510) | (16,343,510) | ||
| Current financial liabilities | (78,100,896) | ||||
| Trade payables | Financial liabilities at amortised cost |
(52,400,843) | (52,400,843) | ||
| Total financial liabilities | (212,759,795) | ||||
| including: | Financial liabilities at amortised cost |
(212,610,769) | - | (128,988,704) | (83,622,065) |
| Derivatives | (149,026) | - | (149,026) | - |


| (in Euros) | Fair value | ||||
|---|---|---|---|---|---|
| 31.12.2020 | IFRS 9 category | Carrying amount |
Level 1 | Level 2 | Level 3 |
| Other financial assets | Loans and receivables | 415 | 415 | ||
| Financial assets with the group | Loans and receivables | 160,000 | 160,000 | ||
| Other non-current financial assets |
160,415 | ||||
| Other current financial assets | Available-for-sale financial assets |
7,520,536 | 7,520,536 | ||
| Financial assets with the group | Loans and receivables | 1,718 | 1,718 | ||
| Other current financial assets | 7,522,254 | ||||
| Trade receivables | Loans and receivables | 36,782,785 | 36,782,785 | ||
| Total financial assets | 44,465,454 | ||||
| including: | Available-for-sale financial assets |
7,520,536 | - | 7,520,536 | - |
| Loans and receivables | 36,944,918 | - | - | 36,944,918 | |
| Bank loans and borrowings | Financial liabilities at amortised cost |
(86,908,727) | (86,908,727) | ||
| Other loans and borrowings | Financial liabilities at amortised cost |
(872,416) | (872,416) | ||
| Lease liabilities | Financial liabilities at amortised cost |
(13,635,510) | (13,635,510) | ||
| Effective derivatives | Derivatives | (578,334) | (578,334) | ||
| Non-current financial liabilities | (101,994,987) | ||||
| Current bank loans | Financial liabilities at amortised cost |
(42,462,870) | (42,462,870) | ||
| Other loans and borrowings | Financial liabilities at amortised cost |
(314,653) | (314,653) | ||
| Lease liabilities | Financial liabilities at amortised cost |
(1,351,377) | (1,351,377) | ||
| Effective derivatives | Derivatives | (2,744) | (2,744) | ||
| Financial liabilities with group companies |
Financial liabilities at amortised cost |
(11,632,329) | (11,632,329) | ||
| Current financial liabilities | (55,763,973) | ||||
| Trade payables | Financial liabilities at amortised cost |
(37,634,976) | (37,634,976) | ||
| Total financial liabilities | (195,393,936) | ||||
| including: | Financial liabilities at amortised cost |
(194,812,858) | - | (130,558,666) (64,254,192) | |
| Derivatives | (581,078) | - | (581,078) | - |

As the company sells its products in various countries around the world, it is exposed to the risk deriving from changes in foreign exchange rates. This risk mainly arises on purchases and sales in currencies like the US dollar, the Polish zloty and the Japanese yen.
The company agrees currency hedges to set the exchange rate in line with forecast sales and purchases volumes to protect itself against currency fluctuations with respect to its foreign currency transactions. The hedges are based on the company's net exposure using currency forwards and/or plain vanilla options in line with the group's financial policy. The hedged risk is part of the global risk and the hedges are not speculative.
This is the risk that the fair value and/or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.
The company is exposed to interest rate risk due to its need to finance its operating activities, both production and financial (the purchase of assets), and to invest its available liquidity. Changes in market interest rates may negatively or positively affect the company's results and, hence, indirectly the cost of and return on financing and investing activities.
The company regularly checks its exposure to interest rate fluctuations and manages such risks through the use of derivatives, in accordance with its risk management policies. With regard to such policies, the use of derivatives is reserved exclusively for the management of interest rate fluctuations connected to cash flows and they are not agreed or held for trading purposes.
It solely uses interest rate swaps (IRS), caps and collars to do so.
The company's debt mainly bears floating interest rates. When deemed significant, the company agrees hedges to neutralise fluctuations in interest rates and agrees a set future expense to cover up to 100% of its future cash outflows.
Given its ample liquidity, it has an immaterial liquidity risk with respect to its short-term deadlines and, therefore, this risk principally refers to its medium to long-term financing. In 2021, notwithstanding the difficult market conditions caused by the continuation of the Covid-19 pandemic, the company had significant access to credit at reduced interest rates. Therefore, it is not believed that interest rate risk increased during the year.
The derivatives used to hedge such risk are generally cash flow hedges in order to set the interest to be paid on financing and obtain an optimum blend of floating and fixed interest rates applied to its financing.
The counterparties are major banks. Derivatives are measured at fair value.


The company is subjected to increasing competitive pressure due to the entry of new players into the OEM market (large international groups) and the development of new organised markets which constantly push prices down, especially in the electronics sector.
Demand for the group's products is also affected by fluctuations affecting the distribution channels of products and applications which, as noted, are mostly the OEM operating indirectly in the construction sector and operators linked to the food distribution sector (for the refrigeration business).
The company protects itself from the business risks deriving from its normal involvement in markets with these characteristics by focusing on technological innovation and geographical diversification and expansion leading to the company gaining international status as it is active on all the continents either directly or through exclusive third party franchisees.
The production sites in Italy, China, Brazil, the United States, Croatia and Germany aim to optimise production. They will also act as potential disaster recovery centres to deal with catastrophes that shut down production at the main site in Italy, where the parent has its registered office. The company's strategy is also to base its production near its markets and customers to provide faster time-to-market services and increase its production output to serve the rapidly growing markets.
The continuing production structure reorganisation, the related cost savings, geographical diversification and, last but not least, the company's constant commitment to searching for innovative technological solutions make it easier to be competitive.
In 2021, demand for group products did not significantly slow down due to the Covid-19 pandemic. The dynamics of the different markets, in terms of both their geographical size and product families, included in legislative measures, were closely monitored, both in order to adjust commercial, procurement and production policies and to identify opportunities to develop new products.
Lastly, the company is exposed to risks of purchase prices fluctuations and availability of certain raw materials used in the different production processes, specifically semiconductors. These risks have also increased as a result of the continuation of the pandemic. In line with measures adopted in the previous year, it rolled out processes to procure supplies from various sources in order to mitigate the risk of shortages or excessive purchase price fluctuations.
Once again in 2021, like in the previous year, environmental and social issues and their impact on climate change have influenced political and cultural debate, becoming increasingly central to an entity's engagement with its stakeholders. The financial community is especially sensitive to these issues as they continue to intertwine with business operations and strategies in terms of an entity's development (for example, considering the large investments the EU plans to make in coming years in climate change mitigation and adaptation actions and for the transition to more sustainable energy sources) and riskiness (which includes all facets of ESG - Environment, Social Governance).

The group reiterated its commitment to increasingly sustainable development with a number of initiatives (some of which have already been launched) culminating with the publication of its long-term sustainability plan hinged on the concept Driven by the Future - Sustainability in action.
More information is available in the group's 2021 consolidated non-financial statement.
The directors do not currently believe that there are specific risks that climate change could impact the assets of the company and the group that should be considered, for example, as part of the forward-looking information underlying impairment testing, since there are no production and commercial sites in high-risk areas.


The changes shown below are calculated using the balances at 31 December 2020 related to the statement of financial position and for 2020 with regard to the statement of profit or loss. As already mentioned, amounts are in Euros.
The following table provides an analysis of the changes in property, plant and equipment over the two years:
| (in Euros) | Buildings | Light constructions |
Plant and machinery |
Industrial and commercial equipment |
Other items of property, plant and equipment |
Assets under construction and payments on account |
Total |
|---|---|---|---|---|---|---|---|
| Historical cost | 17,141,208 | 10,709 | 13,200,276 | 28,852,759 | 8,764,049 | 702,333 | 68,671,334 |
| Accumulated depreciation and impairment losses |
(2,197,168) | (5,686) | (10,324,842) | (24,243,241) | (6,879,549) | - | (43,650,486) |
| Balance at 31 December 2020 |
14,944,040 | 5,023 | 2,875,434 | 4,609,518 | 1,884,500 | 702,333 25,020,848 | |
| Changes in 2021 | |||||||
| Investments | 116,986 | - | 1,204,601 | 2,330,611 | 369,598 | 362,780 | 4,384,576 |
| Investments in right-of use assets |
- | - | - | - | 230,943 | 230,943 | |
| Restatement of right-of use assets |
(241,700) | - | - | - | 7,381 | - | (234,319) |
| Reclassifications | 7,879 | - | 23,752 | 618,644 | 14,554 | (664,829) | - |
| Termination of investments in right-of use assets |
(2,224,133) | - | - | - | (170,590) | - | (2,394,723) |
| Disinvestments - cost | - | - | (365,904) | (377,124) | (115,144) | (21,487) | (879,659) |
| Disinvestments - accumulated depreciation |
- | - | 330,455 | 358,140 | 113,692 | - | 802,287 |
| Depreciation | (19,129) | (1,071) | (491,322) | (2,193,135) | (494,987) | - | (3,199,644) |
| Depreciation of right-of use assets |
(1,134,395) | - | - | - | (300,882) | - | (1,435,277) |
| Termination of inv. in right-of-use assets - Acc. depr. |
2,074,061 | - | - | - | 165,677 | - | 2,239,738 |
| Total changes | (1,420,431) | (1,071) | 701,582 | 737,136 | (179,758) | (323,536) | (486,078) |
| Balance at 31 December 2021 |
13,523,609 | 3,952 | 3,577,016 | 5,346,654 | 1,704,742 | 378,797 | 24,534,770 |
| including: | |||||||
| Historical cost | 14,800,240 | 10,709 | 14,062,725 | 31,424,890 | 9,100,791 | 378,797 | 69,778,152 |
| Accumulated depreciation and impairment losses |
(1,276,631) | (6,757) | (10,485,709) | (26,078,236) | (7,396,049) | - | (45,243,382) |

Buildings include leasehold improvements that are not economically separable from the assets in use on the leased buildings where the company operates (€125 thousand).
Plant and machinery include generic and specific plant related to production lines for a total of €3,577 thousand. Increases in generic plant include a new LED lighting system (€50 thousand), a new fumes intake system (€37 thousand) and the upgrading of the electrical system (€32 thousand). The increases in specific plant include a new welding machine (€200 thousand), two new YMS surface fitting systems (€269 thousand), a new component testing machine (€56 thousand), a new aspiration system for the valve line (€52 thousand) and the integration of the valve line (€36 thousand). Specific plant includes divestments of €342 thousand, mainly scrapping of obsolete items or sales to group companies for new production lines.
The increase in industrial and commercial equipment mostly relates to moulds, testing machines and other production equipment. It also comprises a valve testing system (€183 thousand), a camera vision system (€114 thousand), two 3D optical inspection systems (€139 thousand) and two elastometer assembly systems (€100 thousand).
Equipment includes divestments of €399 thousand, mainly scrapping of obsolete and disused items or sales to subsidiaries for new production lines.
Increases in other items of property, plant and equipment mainly include new right-of-use assets relating to leased vehicles of €238 thousand, furniture and fittings of €116 thousand, office and electronic machines of €230 thousand, internal means of transport of €10 thousand and telephone systems of €28 thousand.
The decrease is mostly due to the replacement of electronic office equipment (mainly as part of the upgrading of the company's information systems), owned cars, telephone systems and internal means of transport.
Assets under construction include payments on account and self-constructed machinery not yet completed at the reporting date.
Depreciation amounts to €4,635 thousand and was calculated based on all depreciable assets at 31 December 2021, applying the criteria and rates indicated in the section on Property, plant and equipment.
The company's property, plant and equipment were not mortgaged or pledged at 31 December 2021. They are suitably hedged for risks deriving from losses and/or damage thereto through insurance policies taken out with leading insurers.
Lastly, in line with previous years, the company did not capitalise borrowing costs.


The following table provides an analysis of the changes in intangible assets over the two years.
| (in Euros) | Development expenditure |
Software | Goodwill | Assets under development and payments on account |
Other assets | Total |
|---|---|---|---|---|---|---|
| Historical cost | 23,432,924 | 17,114,816 | 1,618,357 | 3,574,531 | 80,216 | 45,820,844 |
| Accumulated amortisation and impairment losses |
(18,904,191) | (13,573,040) | (1,259,765) | - | (56,706) | (33,793,702) |
| Balance at 31 December 2020 |
4,528,733 | 3,541,776 | 358,592 | 3,574,531 | 23,510 | 12,027,142 |
| Changes in 2021 | ||||||
| Investments | - | 1,804,492 | - | 1,292,287 | - | 3,096,779 |
| Internal cost capitalisation |
276,874 | - | - | - | - | 276,874 |
| Reclassifications | 2,429,313 | 198,616 | - | (2,627,929) | - | - |
| Sales | - | - | - | (3,500) | - | (3,500) |
| Amortisation | (1,725,327) | (2,152,393) | - | - | (12,515) | (3,890,235) |
| Total changes | 980,860 | (149,285) | - | (1,339,142) | (12,515) | (520,082) |
| Balance at 31 December 2021 |
5,509,593 | 3,392,491 | 358,592 | 2,235,389 | 10,995 | 11,507,060 |
| including: | ||||||
| Historical cost | 26,139,111 | 19,117,924 | 1,618,357 | 2,235,389 | 80,216 | 49,190,997 |
| Accumulated amortisation and impairment losses |
(20,629,518) | (15,725,433) | (1,259,765) | - | (69,221) | (37,683,937) |
Development expenditure: in 2021, the company capitalised development expenditure of €2,706 thousand related to projects developed internally, of which €277 thousand related to 2021 and €2,429 thousand related to projects that were ongoing at the previous year end and were completed in 2021.
Amortisation is applied over the estimated useful life of five years.
Capitalised development expenditure refers entirely to the development of projects for the production of new innovative products or substantial improvements to existing products. The capitalisation is based on feasibility studies and business plans approved by management.
Software refers to management programs and network applications. Investments of the year mainly related to new implementations of the Oracle management system to support the relevant departments.
Goodwill refers to the goodwill arising on the merger of the wholly-owned Carel Applico S.r.l. on 1 September 2015.
The increase in assets under development and payments on account may be analysed as follows:
Lastly, intangible assets were not revalued during the year, nor in previous years and the acquisition cost does not include borrowing costs.

| Subsidiaries | Associates and other | Total | |
|---|---|---|---|
| (in Euros) | companies | ||
| Balance at 31 December 2020 | 117,364,095 | 133,762 | 117,497,857 |
| Changes in 2021 | |||
| Initial cost: | |||
| Increases | 34,496,960 | 27,500 | 34,524,460 |
| Impairment gains | 914,645 | 42,358 | 957,003 |
| Total changes | 35,411,605 | 69,858 | 35,481,463 |
| Balance at 31 December 2021 | 152,775,700 | 203,620 | 152,979,320 |
Changes in the carrying amount of equity investments during the year refer to the following investees:
| (in Euros) | 2021 |
|---|---|
| Subsidiaries | |
| CFM Sogutma ve Otomasyon A.S. | 34,496,960 |
| Associates and other companies | |
| Arion S.r.l | - |
| Smact Società Consortile per azioni | 15,000 |
| Fondazione ITS Academy "Mario Volpato" | 12,500 |
| Total increases | 34,524,460 |
On 31 May 2021, the company acquired 51% of share capital of CFM Sogutma ve Otomasyon A.S. ("CFM"), a Turkish company with registered office in Izmir (Turkey) that is a long-standing Carel product distributor and partner in the region, for a cash consideration of €26,512 thousand.
At the reporting date, part of the consideration (€1,440 thousand) has been recognised as a non-current financial liability as per the acquisition agreement as a warranty and to cover any possible contractual risks to be borne by the seller. The latter amount will be paid in instalments when certain contractually-agreed events occur. As meeting these conditions is deemed probable, management considers such amount an adjustment of the consideration paid at the acquisition date.
Furthermore, under the acquisition agreement, the interest held by the non-controlling investor is subject to mutual put and call options. Specifically, the non-controlling investor's put option can be exercised within 30 days of the approval of the company's financial statements for each year from 2024 to 2026 on all of the company's remaining shares (i.e. 49%) at an amount calculated using a specific multiple applicable to the company's average gross operating profit over the three years prior to the year when the put option is exercised and adjusted to take into consideration the company's net financial position. The company can exercise the call option any time after the put option expires and up to 31 December 2027. The option includes rewarding mechanisms if the company's performance exceeds expectations.


The call option was measured at its fair value at the acquisition date and at 31 December 2021. The directors engaged an independent expert to determine such fair value by estimating the most probable scenario in which the option would be exercised, based on a high number of possible gross operating profit and equity value scenarios based respectively on the Bachelier and Black-Scholes frameworks.
The option's acquisition-date fair value of €7,985 thousand has been recognised under equity investments, concurrently recognising the same amount under other non-current liabilities as a balancing entry. The fair value gain on the liability at the reporting date (€61 thousand) has been recognised under other financial income.
The directors compared the carrying amount of the equity investments to the company's share of each investee's equity. Since the carrying amount of the following equity investments that underwent impairment in previous years exceeded the company's share of their equity, the directors decided to recognise a writedown recovery thereon as they believed the investees will continue to recognise a profit in the coming years:
| (in Euros) | 2021 |
|---|---|
| Subsidiaries | |
| Carel Asia Ltd | 285,396 |
| Carel Controls Iberica SL | 586,143 |
| Carel Middle East DWC Llc | 43,106 |
| Associates | |
| Arion S.r.l. | 42,358 |
| Total impairment gains | 957,003 |
The directors tested the investments in the subsidiaries HygroMatik, Recuperator and CFM, whose carrying amount was €57,216 thousand, €22,044 thousand and €34,497 thousand, respectively, for impairment pursuant to IAS 36, since the continuation of the Covid-19 pandemic was considered a trigger event, as in the previous year.
The recoverable amount of equity investments is determined by calculating their value in use.
The methods and assumptions underlying the impairment tests of the CGUs included:

| Plan horizon | Growth rate g | WACC | Plan approval date | |
|---|---|---|---|---|
| Recuperator | 2022-2025 | 1.50% | 8.43% | 18.02.2022 |
| Hygromatik | 2022-2025 | 2.00% | 8.24% | 10.02.2022 |
| CFM | 2022-2026 | 1.00% | 13.05% | 16.02.2022 |
The values in use, calculated using the discounted cash flows, confirm the carrying amount of all three CGUs.
Although the directors believe that the assumptions used are reasonable and represent the most probable scenarios based on the available information, the result of the test could differ should the above assumptions significantly change. Specifically, the growth estimates could change considerably due to the continuation of the pandemic or in the event of an upsurge of the pandemic in certain geographical segments.
Accordingly, stress tests were carried out, related, in particular, to:
These stress tests reveal that the following equity investments passed the test even if the gross operating profit decreases or the WACC increases as set out below:
| Gross operating profit +/- | WACC +/- | |
|---|---|---|
| Recuperator | -7,00% | 0,20% |
| Hygromatik | -90,00% | 1,50% |
| CFM | -55,00% | 2,80% |
Therefore, there was no indication of impairment of the above equity investments.
At 31 December 2021, the company has not accrued a provision for equity investment risks, recognised in the non-current provisions for the recapitalisation obligations of the investees.


| 31.12.2021 | 31.12.2020 | |||||
|---|---|---|---|---|---|---|
| (in Euros) | Historical cost | Acc. impairment losses |
Carrying amount |
Historical cost | Acc. impairment losses |
Carrying amount |
| Subsidiaries: | ||||||
| Recuperator S.p.A. | 25,743,625 | (3,700,000) | 22,043,625 | 25,743,625 | (3,700,000) | 22,043,625 |
| Carel Deutschland Gmbh | 138,049 | - | 138,049 | 138,049 | - | 138,049 |
| Carel Adriatic d.o.o. | 7,370,289 | - | 7,370,289 | 7,370,289 | - | 7,370,289 |
| C.R.C S.r.l. | 1,600,000 | - | 1,600,000 | 1,600,000 | - | 1,600,000 |
| HygroMatik Gmbh | 57,216,335 | - | 57,216,335 | 57,216,335 | - | 57,216,335 |
| Carel France Sas | 91,469 | - | 91,469 | 91,469 | - | 91,469 |
| Carel Sud America Ltda | 5,396,848 | (1,983,740) | 3,413,108 | 5,396,848 | (1,983,740) | 3,413,108 |
| Carel U.K. Ltd | 1,624,603 | - | 1,624,603 | 1,624,603 | - | 1,624,603 |
| Carel Asia Ltd | 1,761,498 | - | 1,761,498 | 1,761,498 | (285,396) | 1,476,102 |
| Carel Electronic (Suzhou) Co. Ltd |
9,276,379 | - | 9,276,379 | 9,276,379 | - | 9,276,379 |
| Carel Controls Iberica SL | 4,330,149 | (624,577) | 3,705,572 | 4,330,149 | (1,210,720) | 3,119,429 |
| Carel RUS Llc | 160,936 | 160,936 | 160,936 | 160,936 | ||
| Carel Usa Llc | 5,466,439 | 5,466,439 | 5,466,439 | 5,466,439 | ||
| Carel Nordic AB | 60,798 | 60,798 | 60,798 | 60,798 | ||
| Carel Middle East | 1,060,614 | (961,495) | 99,119 | 1,060,614 | (1,004,601) | 56,013 |
| Alfaco Polska Sp.z.o.o. | 3,820,413 | - | 3,820,413 | 3,820,413 | - | 3,820,413 |
| Carel Japan Co. Ltd | 475,003 | (44,895) | 430,108 | 475,003 | (44,895) | 430,108 |
| CFM Sogutma ve Otomasyon A.S. |
34,496,960 | - | 34,496,960 | - | - | - |
| Total | 160,090,407 | (7,314,707) | 152,775,700 | 125,593,447 | (8,229,352) | 117,364,095 |
| Associates: | ||||||
| Arion S.r.l | 140,000 | - | 140,000 | 140,000 | (42,358) | 97,642 |
| Total | 140,000 | - | 140,000 | 140,000 | (42,358) | 97,642 |
| Other companies: | ||||||
| CONAI | 45 | - | 45 | 45 | - | 45 |
| Smact Società Consortile per azioni |
51,075 | - | 51,075 | 36,075 | - | 36,075 |
| Fondazione ITS Academy "Mario Volpato" |
12,500 | - | 12,500 | - | - | - |
| Total | 63,620 | - | 63,620 | 36,120 | - | 36,120 |
| Total equity investments |
160,294,027 | (7,314,707) | 152,979,320 | 125,769,567 | (8,271,710) | 117,497,857 |

Investment percentage
The following table provides the information about equity investments at 31 December 2021 required by article 2427 of the Italian Civil Code:
| (in Euros) | Registered office | Currency | Share/quota capital (in currency) |
|---|---|---|---|
| Subsidiaries: | |||
| Carel Deutschland GmbH | Frankfurt | EUR | 25,565 |
| Carel Adriatic d.o.o. | Labin-HR | HRK | 54,600,000 |
| C.R.C S.r.l. | Bologna-IT | EUR | 98,800 |
| Carel France Sas | St. Priest, Rhone-FR | EUR | 100,000 |
| Carel Sud America Instrumentacao Eletronica Ltda | São Paulo-BR | BRL | 31,149,059 |
| Carel U.K. Ltd | London-GB | GBP | 350,000 |
| Carel Asia Ltd | Honk Kong-HK | HKD | 15,900,000 |
| Carel Electronic (Suzhou) Co. Ltd | Suzhou-RC | CNY | 75,019,566 |
| Carel Controls Iberica SL | Barcelona-ES | EUR | 3,005 |
| Carel RUS Llc | St. Petersburg-RU | RUB | 6,600,000 |
| Carel Usa Llc | Wilmington Delaware USA |
USD | 5,000,000 |
| Carel Nordic AB | Höganäs-SE | SEK | 550,000 |
| Carel Middle East | Dubai-UAE | AED | 4,333,878 |
| Alfaco Polska Sp.z.o.o. | Wrocław-PL | PLN | 420,000 |
| Recuperator S.p.A. | Rescaldina-IT | EUR | 500,000 |
| HygroMatik GmbH | Henstedt-Ulzburg-DE | EUR | 639,115 |
| Carel Japan Co. Ltd | Tokyo-JP | JPY | 60,000,000 |
| CFM Soğutma ve Otomasyon Anonim Şirketi | Izmir-TR | TRY | 2,565,400 |
| Total | |||
| Associates: | |||
| Arion S.r.l (*) | Brescia-IT | EUR | 100,000 |
| Total | |||
| Other companies: | |||
| CONAI | EUR | ||
| SMACT Società Consortile per azioni | EUR | ||
| Fondazione ITS Academy "Mario Volpato" | EUR | ||
| Total | |||
| Total equity investments | |||
(*) amounts at 31.12.2020


(*) amounts at 31.12.2020
| Equity diff. % and carrying amount (Euro) |
Carrying amount (Euro) |
Indirect | Direct | Profit/loss for the year (Euro) |
Equity (Euro) | |
|---|---|---|---|---|---|---|
| 3,507,655 | 138,049 | 100.00% | 2,740,965 | 3,645,704 | ||
| 17,642,915 | 7,370,289 | 100.00% | 5,018,539 | 25,013,204 | ||
| 3,432,622 | 1,600,000 | 100.00% | 1,006,045 | 5,032,622 | ||
| 3,455,480 | 91,469 | 100.00% | 1,542,492 | 3,546,949 | ||
| (115,380) | 3,413,108 | 46.98% | 53.02% | 725,607 | 6,219,781 | |
| 2,023,786 | 1,624,603 | 100.00% | 780,914 | 3,648,389 | ||
| 833,171 | 1,761,498 | 100.00% | 965,448 | 2,594,669 | ||
| 49,870,546 | 9,276,379 | 100.00% | 8,860,203 | 59,146,925 | ||
| 3,705,572 | 100.00% | 1,086,135 | 3,705,572 | |||
| 1,180,408 | 160,936 | 1.00% | 99.00% | 766,473 | 1,354,893 | |
| 17,911,824 | 5,466,439 | 100.00% | 4,387,128 | 23,378,263 | ||
| 884,900 | 60,798 | 100.00% | 376,013 | 945,698 | ||
| 99,119 | 100.00% | 36,804 | 99,119 | |||
| 6,220,994 | 3,820,413 | 100.00% | 3,588,710 | 10,041,407 | ||
| (11,561,561) | 22,043,625 | 100.00% | 582,470 | 10,482,064 | ||
| (46,614,760) | 57,216,335 | 100.00% | 3,414,278 | 10,601,575 | ||
| (144,855) | 430,108 | 100.00% | 45,768 | 285,253 | ||
| (28,052,796) | 34,496,960 | 51.00% | 1,683,539 | 12,635,616 | ||
| 152,775,700 | ||||||
| 19,496 | 140,000 | 40.00% | 154,637 | 398,741 | ||
| 140,000 | ||||||
| 45 | ||||||
| 51,075 | ||||||
| 12,500 | ||||||
| 63,620 | ||||||
| 152,979,320 |
| Variation | |||||
|---|---|---|---|---|---|
| 31.12.2021 | Increases | Reclassification | Decreases | 31.12.2020 | |
| (in Euros) | |||||
| Subsidiaries | 14,404,493 | 14,404,493 | - | - | |
| Associates | - | - | (160,000) | - | 160,000 |
| Substitute tax | 7,206,818 | (1,698,875) | - | 8,905,693 | |
| Other tax assets | 1,703,741 | 1,253,462 | (357,304) | (11,290) | 818,873 |
| Effective designated derivative hedges |
81,766 | 81,766 | - | ||
| Others | - | - | (415) | 415 | |
| TOTAL | 23,396,818 | 15,739,721 | (11,705) | 9,884,981 | |
These amount to €23,397 thousand and can be analysed as follows:
Amounts due from subsidiaries increased due to the interest-bearing loan granted to Recuperator S.p.A. of a maximum amount of €17.5 million, disbursable in instalments from 23 June 2021 and expiring in June 2026. It may be fully or partly prepaid.
The loan was granted to allow the subsidiary to acquire 100% of share capital of Enginia S.r.l. on 23 June 2021, a company operating in the aeraulic sector in the design, production and marketing of dampers and other plastic and metal components for air handling units, with solutions dedicated to OEM customers.
This transaction is part of the group's strategy to expand the offer of its product portfolio in the HVAC market, consolidating its role as a supplier of complete solutions to manufacturers of air handling units via advanced performance and highly energy efficient solutions. The consideration paid for the acquisition of the equity investment amounts to €17.4 million.
The decrease in amounts due from associates is due to the reclassification of the non-interest-bearing loan granted to Arion S.r.l. to current assets.
The substitute tax reflects the directors' decision in 2019, supported by their consultants, to pay this tax in order to align the higher carrying amounts recognised at the time of the December 2018 acquisition against consideration of Recuperator S.p.A. (Italy) and HygroMatik GmbH (Germany) with the relevant tax bases, as per article 15.10-bis of Decree law no. 185/2008. The decrease is due to the reclassification of the portion related to 2022 to current assets.
The increase in other tax assets refers to amounts accrued during the year ("Industry 4.0 – Law no. 160/2019"; "Maxi-depreciation – Law no. 178/2020; "Ecobonus – Law no. 296/2006"; "Tax credit for research and development activities – Law no. 178/2020") that will be offset against other taxes based on the timeframes set by the relevant laws, net of the reclassification of the portion offsettable in 2022 to current assets.


The effective designated derivative hedges recognised under non-current financial assets include the fair value of IRSs signed to hedge the interest rate risk of the loans. Specifically:
| (in Euros) | ||||
|---|---|---|---|---|
| Lender | Instrument | Notional amount | Maturity | Positive fair value |
| MEDIOBANCA loan | Interest rate swap | 25,000,000 | 04,08,2023 | 9,396 |
| MEDIOBANCA loan | Interest rate swap | 20,000,000 | 29,06,2026 | 72,370 |
| Total | 81,766 |
Deferred tax assets at 31 December 2021 were generated by the temporary differences between the carrying amounts of assets and liabilities and their tax bases calculated with reference to the tax rates expected to be enacted in the years in which the differences will reverse.
The company considered it appropriate to recognise the deferred tax assets arising on the temporary differences indicated below in the separate financial statements, as it is reasonably certain that they will be offset against taxable profits in the years in which the deductible temporary differences will reverse.
| 31.12.2021 | 31.12.2020 | |||
|---|---|---|---|---|
| (in Euros) | Tax base | Deferred tax assets |
Tax base | Deferred tax assets |
| Allowance for inventory write-down | 2,482,325 | 595,758 | 2,001,840 | 480,442 |
| Allowance for doubtful accounts | 44,261 | 10,623 | - | - |
| Provision for product warranties | 294,732 | 82,230 | 222,599 | 62,105 |
| Provision for complaints | 1,982,436 | 553,099 | 2,130,392 | 594,379 |
| Provision for agents' termination indemnity and bonuses |
74,026 | 17,766 | 74,026 | 17,766 |
| Unrealised exchange differences | 437,912 | 105,099 | 305,078 | 73,219 |
| Deductible cash fees | 267,507 | 64,201 | 286,333 | 68,720 |
| Amortisation of goodwill - transfer | 71,050 | 19,822 | 79,217 | 22,101 |
| Substitute tax on goodwill (16%) | 71,050 | 11,369 | 79,217 | 12,676 |
| Amortisation of goodwill - merger | 207,620 | 57,926 | 231,484 | 64,584 |
| Substitute tax on goodwill (12%) | 207,620 | 24,932 | 231,484 | 27,796 |
| Amortisation of goodwill - acquisition of business unit |
3,427 | 957 | 3,822 | 1,067 |
| Discounting - Post-employment benefits and post-term of office benefits |
487,581 | 136,034 | 530,194 | 147,923 |
| Difference between amortisation/ depreciation for IFRS and tax purposes |
293,866 | 81,990 | 213,958 | 59,696 |
| Fair value changes on derivatives | 149,027 | 35,766 | 578,334 | 138,800 |
| Total | 7,074,440 | 1,797,572 | 6,967,978 | 1,771,274 |

| (in Euros) | 31.12.2021 | Recognised in profit or loss |
Recognised in other comprehensive income |
31.12.2020 |
|---|---|---|---|---|
| Allowance for inventory write-down | 595,758 | 115,316 | - | 480,442 |
| Allowance for doubtful accounts | 10,623 | 10,623 | - | - |
| Provision for product warranties | 82,230 | 20,125 | - | 62,105 |
| Provision for complaints | 553,099 | (41,280) | - | 594,379 |
| Provision for agents' termination indemnity and bonuses |
17,766 | - | - | 17,766 |
| Unrealised exchange differences | 105,099 | 31,880 | - | 73,219 |
| Deductible cash fees | 64,201 | (4,519) | - | 68,720 |
| Amortisation of goodwill - transfer | 19,822 | (2,279) | - | 22,101 |
| Substitute tax on goodwill (16%) | 11,369 | (1,307) | - | 12,676 |
| Amortisation of goodwill - merger | 57,926 | (6,658) | - | 64,584 |
| Substitute tax on goodwill (12%) | 24,932 | (2,864) | - | 27,796 |
| Amortisation of goodwill - acquisition of business unit |
957 | (110) | - | 1,067 |
| Discounting - Post-employment benefits and post-term of office benefits |
136,034 | (38,435) | 26,546 | 147,923 |
| Difference between amortisation/ depreciation for IFRS and tax purposes |
81,990 | 22,294 | - | 59,696 |
| Fair value changes on derivatives | 35,766 | - | (103,034) | 138,800 |
| Total | 1,797,572 | 102,786 | (76,488) | 1,771,274 |
These amount to €48,836 thousand (€36,783 thousand at 31 December 2020) and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Third parties | 28,231,010 | 4,937,229 | 23,293,781 |
| Subsidiaries | 21,278,562 | 7,337,447 | 13,941,115 |
| Subsidiaries of parents | 10,382 | (4,874) | 15,256 |
| Related parties | 14,157 | 9,607 | 4,550 |
| Total trade receivables | 49,534,111 | 12,279,409 | 37,254,702 |
| Allowance for doubtful accounts | (698,176) | (226,259) | (471,917) |
| Total | 48,835,935 | 12,053,150 | 36,782,785 |


Trade receivables in foreign currency were retranslated using the closing rate, adjusting the originallyrecognised amount.
Trade receivables, net of the allowance for doubtful accounts, refer to the following geographical segments:
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Europe, Middle East and Africa | 39,118,693 | 29,793,221 |
| APAC | 6,359,828 | 4,538,265 |
| North America | 3,030,918 | 2,186,076 |
| South America | 1,024,672 | 737,140 |
| Total | 49,534,111 | 37,254,702 |
The company does not usually charge default interest on past due receivables. Reference should be made to the section on risks and financial instruments for details of the receivables that are not yet due and/or are past due.
The company's receivables are not particularly concentrated. It does not have customers that individually account for more than 5% of the total receivables at each maturity date.
The allowance for doubtful accounts comprises management's estimates about credit losses on receivables from end customers and the sales network. Management estimates the allowance on the basis of the expected credit losses, considering past experience for similar receivables, current and historical past due amounts, losses and collections, the careful monitoring of credit quality and projections about the economy and market conditions.
Changes in the allowance are shown in the following table:
| Variation | |||||
|---|---|---|---|---|---|
| (in Euros) | 31.12.2021 | Impairment losses |
Utilisations | Reversals | 31.12.2020 |
| Allowance for doubtful accounts | 698,176 | 290,945 | (64,686) | - | 471,917 |
| TOTAL | 698,176 | 290,945 | (64,686) | - | 471,917 |
A breakdown of trade receivables from group companies is as follows.
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| C.R.C. S.r.l. | 141,357 | 117,696 |
| Recuperator S.p.A. | 136,895 | 38,750 |
| Enginia Srl Unipersonale | 68 | - |
| Carel U.K. Ltd | 1,273,582 | 1,394,281 |
| Carel France s.a.s. | 1,916,828 | 1,204,874 |
| Carel Asia Ltd | 1,470,682 | 780,675 |
| Carel Sud America Instrumentacao Eletronica Ltda | 848,184 | 585,251 |
| Carel Usa Llc | 2,896,974 | 2,096,757 |
| Carel Australia Pty. Ltd | 3,708 | |
| Carel Deutschland GmbH | 1,172,199 | 747,070 |
| Carel Electronic (Suzhou) Co Ltd | 3,359,386 | 2,174,835 |
| Carel Controls Iberica S.L. | 1,861,308 | 1,281,805 |
| Carel ACR Systems India (Pvt) Ltd | 695,223 | 621,301 |

| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Carel Controls South Africa (Pty) Ltd | 12,367 | 1,313 |
| Carel Rus Llc | 97,807 | 61,830 |
| Carel Korea Ltd | 83,000 | 140,664 |
| Carel Nordic AB | 2,500 | 1,000 |
| Carel Japan Co. Ltd | 37,375 | 10,907 |
| Carel Mexicana S.De.RL | 133,944 | 89,319 |
| Carel Middle East DWC Llc | 82,056 | 72,500 |
| Alfaco Polska Sp.z.o.o | 1,344,648 | 1,769,833 |
| Carel Adriatic D.o.o. | 2,865,234 | 744,744 |
| HygroMatik GmbH | 3,352 | 5,710 |
| CFM Sogutma Ve Otomasyon San.Tic.A.S. | 839,885 | - |
| Subsidiaries | 21,278,562 | 13,941,115 |
| Eurotest Laboratori S.r.l. | 5,807 | 10,681 |
| Arianna S.p.A. | 4,575 | 4,575 |
| Subsidiaries of parents | 10,382 | 15,256 |
| RN Real Estate S.r.l | 12,444 | 3,050 |
| Tre Valli S.r.l. Società Agricola | - | 1,500 |
| Carel Real Estate Adriatic doo | 1,713 | - |
| Related parties | 14,157 | 4,550 |
These amount to €25,160 thousand. They are comprised as follows, net of the allowance for inventory writedown for slow-moving or obsolete items:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Raw materials and consumables | 18,601,486 | 5,899,616 | 12,701,870 |
| Allowance for inventory write-down | (1,732,638) | (325,573) | (1,407,065) |
| Total raw materials, consumable and supplies | 16,868,848 | 5,574,043 | 11,294,805 |
| Work in progress and semi-finished goods | 1,988,651 | 23,375 | 1,965,276 |
| Allowance for inventory write-down | (180,967) | (103,912) | (77,055) |
| Total work in progress and semi-finished goods | 1,807,684 | (80,537) | 1,888,221 |
| Finished goods | 7,030,851 | 911,148 | 6,119,703 |
| Allowance for inventory write-down | (568,720) | (51,000) | (517,720) |
| Total finished goods | 6,462,131 | 860,148 | 5,601,983 |
| Payments on account | 21,828 | (14,693) | 36,521 |
| Total | 25,160,491 | 6,338,961 | 18,821,530 |
Inventories, gross of the allowance for inventory write-down, increased by a total of €6,834 thousand. This was due to the increase in both raw materials and semi-finished products (€5,923 thousand), in order to pre-empt any critical issues caused by shortages in components, especially electronic materials, which characterised 2021 and is expected to continue in early 2022, and in finished goods (€911 thousand), in order to meet


customer demand.
The company recognised an allowance for inventory write-down to cover the difference between the cost and estimated realisable value of obsolete raw materials and finished goods. The accrual was recognised in the caption Costs of raw materials, consumables and goods and change in inventories of the statement of profit or loss.
Inventories were not pledged or subject to property rights restrictions.
These amount to €1,811 thousand and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| IRES tax asset | 1,625,277 | 448,406 | 1,176,871 |
| IRAP tax asset | 185,524 | (190,332) | 375,856 |
| Total | 1,810,801 | 258,074 | 1,552,727 |
These amount to €5,510 thousand (€5,223 thousand at 31 December 2020) and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Other tax assets | 3,384,517 | 17,613 | 3,366,904 |
| Other assets | 2,125,351 | 269,357 | 1,855,994 |
| Total | 5,509,868 | 286,970 | 5,222,898 |
A breakdown of other tax assets at year end is as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| VAT assets | 326,833 | (416,550) | 743,383 |
| Tax assets | 1,095,035 | 697,937 | 397,098 |
| Substitute tax | 1,962,649 | (263,774) | 2,226,423 |
| Total | 3,384,517 | 17,613 | 3,366,904 |
VAT assets relate to the VAT tax asset at the reporting date.

The substitute tax shows the 2022 portion of the substitute tax paid to align the higher carrying amounts recognised at the time of the December 2018 acquisition against consideration of Recuperator S.p.A. (Italy) and HygroMatik GmbH (Germany) with the relevant tax bases, as per article 15.10-bis of Decree law no. 185/2008, as subsequently amended.
Tax assets are the portion offsettable in 2022 against other taxes and contributions of amounts accrued during the year. These include: "Industry 4.0 – Law no. 160/2019" (€53 thousand); "Maxi-depreciation – Law no. 178/2020" (€396 thousand); "Ecobonus – Law no. 296/2006" (€9 thousand) and "Tax credit for research and development activities – Law no. 178/2020" (€637 thousand).
A breakdown of other assets at year end is as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Advances to suppliers | 146,411 | (12,474) | 158,885 |
| Sundry assets | 325,180 | 8,884 | 316,296 |
| Prepayments related to more than one year | 30,231 | (12,797) | 43,028 |
| Other prepayments | 1,623,529 | 285,744 | 1,337,785 |
| Total | 2,125,351 | 269,357 | 1,855,994 |
Advances to suppliers refer to payments on account for services.
Sundry assets include residual insurance compensation of €320 thousand. The insurance appraisers will complete their reports on the reconditioning of the units that lost functionality before 31 March 2022 after which the insurance company will pay the balance.
Prepayments and accrued income refer to income or charges collected/paid before or after the year to which they pertain. They are recognised regardless of the payment or collection date when the related income and charges are common to two or more years and can be allocated over time.
Other prepayments include costs pertaining to the subsequent year including €777 thousand for software maintenance instalments, €528 thousand for insurance premiums and €130 thousand for fairs and exhibitions.


These amount to €665 thousand (€7,522 thousand at 31 December 2020) and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Subsidiaries | 500,167 | 500,167 | - |
| Associates | 160,000 | 160,000 | - |
| Other financial assets | - | (7,520,536) | 7,520,536 |
| Cash pooling arrangement | 612 | (1,106) | 1,718 |
| Derivatives | 4,621 | 4,621 | - |
| Total | 665,400 | (6,856,854) | 7,522,254 |
Amounts due from subsidiaries relate to the interest-bearing loan granted to C.R.C S.r.l. in November 2021, expiring on 31 May 2022.
Amount due from associates relate to the non-interest bearing loan granted to Arion S.r.l., expiring on 31 December 2022, which was reclassified from non-current assets.
Other financial assets referred to temporary deposits of liquidity, including accrued interest income gross of tax withholdings, at banks, which were recovered during the year.
The cash pooling arrangement includes the credit balances of the cash pooling account related to the cash pooling arrangements regarding the following group companies:
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Alfaco Polska Sp.z.o.o. | 612 | 1,696 |
| HygroMatik GmbH | - | 22 |
| Total | 612 | 1,718 |
Derivatives are forwards or currency options agreed to hedge commercial transactions, but do not qualify for hedge accounting. Fair value gains or losses are recognised in profit or loss. The following table reclassifies derivatives by type of financial instrument.
| 31.12.2021 | 31.12.2020 | |||||||
|---|---|---|---|---|---|---|---|---|
| Fair value ** |
Nominal amount ** |
Currency purchases* |
Currency sales* |
Fair value ** |
Nominal amount ** |
Currency purchases* |
Currency sales* |
|
| USD options | 4,621 | 3,429,888 | - | 4,100,000 | - | - | - | - |
| Total | 4,621 | - |
* In foreign currency
** In Euros

This caption comprises temporary liquidity in bank accounts and petty cash and amount to €53,647 thousand.
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Bank accounts | 56,641,613 | (17,058,740) | 70,700,353 |
| Cash and cash equivalents | 5,301 | 90 | 5,211 |
| Totale | 53,646,914 | (17,058,650) | 70,705,564 |
Cash and cash equivalents are not subject to any obligations or use restrictions by the company.
For more information about changes in such caption, reference should be made to the statement of cash flows.
Equity is comprised as follows and underwent the following changes:
| 31.12.2021 | Changes | 31.12.2020 | |||||
|---|---|---|---|---|---|---|---|
| (in Euros) | Total changes | Allocation of prior year profit |
Reclassification | Dividends | Comprehensive income |
||
| Share capital | 10,000,000 | - | 10,000,000 | ||||
| Share premium reserve | 867,350 | - | 867,350 | ||||
| Revaluation reserves | 3,424,658 | - | 3,424,658 | ||||
| Legal reserve | 2,000,000 | - | 2,000,000 | ||||
| Treasury shares | (1,107,870) | 657,030 | 657,030 | (1,764,900) | |||
| Hedging reserve | (51,118) | 384,639 | 384,639 | (435,757) | |||
| Other reserves | |||||||
| - Extraordinary reserve | 54,250,988 | 9,059,322 | 8,916,103 | 151,342 | (8,123) | 45,191,666 | |
| - Transfer premium reserve | 6,105,327 | - | 6,105,327 | ||||
| - Reserve for unrealised exchange gains |
- | (117,257) | - | (117,257) | 117,257 | ||
| - IFRS FTA reserve | 2,145,495 | - | 2,145,495 | ||||
| - Stock grant reserve | 1,311,470 | 127,355 | (34,085) | 161,440 | 1,184,115 | ||
| - Actuarial reserve | (371,714) | (80,366) | (80,366) | (291,348) | |||
| Retained earnings | 476,149 | - | - | 476,149 | |||
| Profit for the year | 27,318,447 | 6,422,529 | (8,916,103) | (11,979,815) | 27,318,447 | 20,895,918 | |
| Total | 106,369,182 | 16,453,252 | - | (11,987,938) | 28,441,190 | 89,915,930 |
The fully paid-up and subscribed share capital consists of 100,000,000 ordinary shares without a nominal amount for a total of €10,000,000.
The company's shares are not pledged as guarantees or liens.


The share premium reserve includes the carrying amount resulting from the company's merger of the industrial and commercial business units of the former Samos S.r.l. in 2013.
The revaluation reserve includes the revaluation, net of taxes, of property, plant and equipment acquired in 2009 following the transfer of the production business unit from the former parent.
The legal reserve has reached the limit set by article 2430 of the Italian Civil Code.
Treasury shares number 100,521. In April 2021, the company assigned 67,688 treasury shares upon conclusion of the first vesting period (2018-2020). The related rights had been granted on 1 October 2018. The 12 beneficiaries were approved by the board of directors on 4 March 2021. The shares assigned were measured using the rolling FIFO method.
The company did not repurchase any treasury shares during the year.
The hedging reserve includes the fair value gains or losses, net of deferred taxes, on the effective portion of five IRSs entered into to hedge the interest rate risk of floating-rate non-current loans entered into in 2018, 2019, 2020 and 2021. The changes are shown in the following table:
| (435,757) |
|---|
| 506,104 |
| (121,465) |
| 384,639 |
| (51,118) |
The increase in the extraordinary reserve is mainly due to the resolution passed by the shareholders in their meeting of 20 April 2021 which approved the separate financial statements at 31 December 2020.
The dividends were distributed to the beneficiaries of the assigned treasury shares.
The transfer premium reserve includes the residual balance of the reserve set up in May 2009 following the transfer of the operating business unit from the former parent.
In their meeting of 20 April 2021 called to approve the separate financial statements at 31 December 2020, the shareholders acknowledged the adjustment to the undistributable reserve for unrealised exchange gains as per article 2426-bis of the Italian Civil Code.
The IFRS FTA reserve was set up upon the adoption of the International Financial Reporting Standards on 1 January 2015.
The stock grant reserve includes the fair value at 31 December 2021 of the incentive plan based on financial instruments for the free assignment of the company's ordinary shares approved by the shareholders on 7 September 2018.

| (in Euros) | |
|---|---|
| 31 December 2020 | 1,184,115 |
| Variation | |
| Portion for the year | 818,469 |
| Rights vested during the year | (657,029) |
| Reclassification to income-related reserve | (34,085) |
| Total changes | 127,355 |
| 31 December 2021 | 1,311,470 |
In March 2021, the company's board of directors approved the assignment of treasury shares upon conclusion of the vesting period (2018-2020). See the comment on treasury shares for more information.
As a result, the company reversed the fair value accumulated in equity for this equity-settled performance plan. The gain between the fair value of the shares assigned, measured using the rolling FIFO method, and their fair value at the grant date was reclassified to an available income-related reserve.
For more information, reference should be made to the section on "Cash-settled and equity-settled payment arrangements" of note [33].
In order to service the incentive plan, the shareholders authorised the repurchase of treasury shares, up to 5,000,000 or 5% of the company's share capital. At the reporting date, the company had 100,521 treasury shares totalling €1,108 thousand.
The actuarial reserve includes the effects of the discounting of the post-employment benefits and post-term of office benefits for directors.
Retained earnings were recognised upon first-time adoption of the IFRS and relate to 2015 and 2016.
Equity captions are broken down by origin, possible use and distribution and their actual use in the past three years below:
| Use in the past three years | |||||||
|---|---|---|---|---|---|---|---|
| (in Euros) | |||||||
| Amount | Possible use | Available portion |
Distributable portion |
To cover losses |
Distribution of reserves |
||
| Share capital | 10,000,000 | ||||||
| Equity-related reserves: | |||||||
| Share premium reserve | 867,350 | A, B, C | 867,350 | 867,350 | |||
| Revaluation reserves | 3,424,658 | A, B, C | 3,424,658 | 3,424,658 | |||
| Transfer premium reserve | 6,105,327 | A, B, C | 6,105,327 | 6,105,327 | |||
| Reserve for treasury shares | (1,107,870) | ||||||
| Income-related reserves: | |||||||
| Legal reserve | 2,000,000 | B | 2,000,000 | ||||
| Extraordinary reserve | 54,250,988 | A, B, C | 53,143,118 | 43,355,060 | 30,000,000 |


| (in Euros) | ||||||
|---|---|---|---|---|---|---|
| Amount | Possible use | Available portion |
Distributable portion |
To cover losses |
Distribution of reserves |
|
| Reserve for unrealised exchange gains |
- | A, B | - | |||
| IFRS FTA reserve | 2,145,495 | B | 2,145,495 | |||
| Actuarial reserve | (371,714) | (371,714) | ||||
| Hedging reserve | (51,118) | (51,118) | ||||
| Stock grant reserve | 1,311,470 | B | 1,311,470 | |||
| Retained earnings | 476,149 | B | 476,149 | |||
| Total (net of profit for 2021) | 79,050,735 | 69,050,735 | 53,752,395 | - | 30,000,000 | |
| Profit for 2021 | 27,318,447 | |||||
| Total equity | 106,369,182 | |||||
Key:
A: share capital increases
B: to cover losses
C: dividends
Pursuant to article 2426.5 of the Italian Civil Code, start-up and capital costs and development expenditure pertaining to more than one year may be recognised as assets with the approval of the board of statutory auditors and they are amortised over five years. Until the amortisation is complete, dividends may only be distributed if there are sufficient available reserves to cover the amount of non-amortised costs.
At 31 December 2021, development expenditure not yet amortised amounts to €6,899,962.
The following table provides an indication of the tax regime for the share capital and reserves at 31 December 2021 in case of their repayment or distribution:
| (in Euros) | Non distributable reserves and earnings |
Taxable share capital and reserves - company |
Taxable share capital and reserves - shareholders |
Non-taxable share capital and reserves - company and shareholders |
Total |
|---|---|---|---|---|---|
| Share capital | 10,000,000 | 10,000,000 | |||
| Share premium reserve | 867,350 | 867,350 | |||
| Revaluation reserves | 3,424,658 | 3,424,658 | |||
| Legal reserve | 2,000,000 | 2,000,000 | |||
| Treasury shares | (1,107,870) | (1,107,870) | |||
| Hedging reserve | (51,118) | (51,118) | |||
| Other reserves | - | ||||
| - Extraordinary reserve | 54,250,988 | 54,250,988 | |||
| - Transfer premium reserve | 6,105,327 | 6,105,327 | |||
| - IFRS FTA reserve | 2,145,495 | 2,145,495 |

| Non distributable reserves and earnings |
Taxable share capital and reserves - company |
Taxable share capital and reserves - shareholders |
Non-taxable share capital and reserves - company and |
Total | |
|---|---|---|---|---|---|
| (in Euros) | shareholders | ||||
| - Stock grant reserve | 1,311,470 | 1,311,470 | |||
| - Actuarial reserve | (371,714) | (371,714) | |||
| Retained earnings | 476,149 | 476,149 | |||
| Total | 4,402,412 | - | 54,250,988 | 20,397,335 | 79,050,735 |
Earnings per share were calculated by dividing the profit attributable to the owners of the company by the weighted average number of outstanding ordinary shares. At 31 December 2021, following the abovementioned repurchase of treasury shares, the weighted average of outstanding ordinary shares was 99,882,557. Earnings per share and the number of ordinary shares used to calculate basic and diluted earnings per share in accordance with IAS 33 are shown below:
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Earnings per share | 27,318,447 | 20,895,918 |
| Average number of ordinary shares | 99,882,557 | 99,851,068 |
| Basic earnings per share | 0.2735 | 0.2093 |
The company's basic and diluted earnings per share are the same.


Non-current loans and borrowings can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Bank loans and borrowings at amortised cost | 67,920,086 | (18,988,641) | 86,908,727 |
| Non-current lease liabilities | 12,108,309 | (1,527,201) | 13,635,510 |
| Other non-current loans and borrowings at amortised cost |
681,246 | (191,170) | 872,416 |
| Effective designated derivative hedges | 108,401 | (469,933) | 578,334 |
| Other non-current financial liabilities | 1,440,014 | 1,440,014 | - |
| Non-current financial liabilities | 82,258,056 | (19,736,931) | 101,994,987 |
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Current portion of bank loans at amortised cost | 60,196,202 | 17,733,332 | 42,462,870 |
| Current lease liabilities | 1,310,656 | (40,721) | 1,351,377 |
| Other current loans and borrowings at amortised cost | 191,170 | (123,483) | 314,653 |
| Current intragroup loans and borrowings | 800,512 | 800,512 | - |
| Effective designated derivative hedges | 40,625 | 37,881 | 2,744 |
| Cash pooling arrangement | 15,542,998 | 3,910,669 | 11,632,329 |
| Other current financial liabilities | 18,733 | 18,733 | - |
| Current financial liabilities | 78,100,896 | 22,336,923 | 55,763,973 |
A breakdown of bank loans and borrowings at amortised cost, net of the interest accrued at the end of the year and the residual amortised cost by due date is provided below:
| LOANS AND BORROWINGS BREAKDOWN AS OF 31ST DECEMBER 2021 | |||||||
|---|---|---|---|---|---|---|---|
| (in Euros) | Currency | Original amount |
Maturity | Rate | Outstanding liabilities in Euros |
Current | Non-current |
| Intesa San Paolo loan | EUR | 6,000,000 | 01/2022 | Fixed | 6,000,000 | 6,000,000 | - |
| BNL (BNP Paribas) loan | EUR | 15,000,000 | 03/2022 | Fixed | 15,000,000 | 15,000,000 | - |
| BNL (BNP Paribas) loan | EUR | 10,000,000 | 08/2022 | Fixed | 10,000,000 | 10,000,000 | - |
| Unicredit S.p.A. loan | EUR | 20,000,000 | 04/2023 | Fixed | 6,666,666 | 4,444,444 | 2,222,222 |
| Unicredit S.p.A. loan | EUR | 20,000,000 | 04/2023 | Floating | 10,000,000 | 6,666,667 | 3,333,333 |
| BNL (BNP Paribas) loan no. 6141372 |
EUR | 20,000,000 | 04/2023 | Floating | 9,995,657 | - | 9,995,657 |
| BNL (BNP Paribas) loan no. 6139218 |
EUR | 30,000,000 | 05/2023 | Floating | 12,839,426 | 8,571,429 | 4,267,997 |
| Mediobanca – Banca di Credito Finanziario S.p.A. loan |
EUR | 25,000,000 | 08/2023 | Floating | 25,001,307 | - | 25,001,307 |

| Currency | Original amount |
Maturity | Rate | Outstanding liabilities in |
Current | Non-current | |
|---|---|---|---|---|---|---|---|
| (in Euros) | Euros | ||||||
| Intesa San Paolo loan | EUR | 10,000,000 | 03/2024 | Fixed | 6,261,790 | 2,499,953 | 3,761,837 |
| Crédit Agricole FriulAdria S.p.A. loan |
EUR | 10,000,000 | 04/2024 | Fixed | 6,267,648 | 2,499,934 | 3,767,714 |
| Mediobanca – Banca di Credito Finanziario S.p.A. loan |
EUR | 20,000,000 | 06/2026 | Floating | 20,014,463 | 4,444,444 | 15,570,019 |
| Total | 128,046,957 | 60,126,871 | 67,920,086 |
All loans bear interest at a rate of less than 1%.
During the year, the company regularly repaid the financing instalment as per the repayment plan. Specifically:
The following loans require compliance with covenants:
At 31 December 2021, such covenants have been respected.
Other non-current financial liabilities show the amount due to the non-controlling investor of CFM for the acquisition of the investment. On 31 May 2021, the company acquired 51% of share capital of CFM, a Turkish company with registered office in Izmir (Turkey) that is a long-standing Carel product distributor and partner in the region.


The sales agreement provides that part of the consideration (€1,440 thousand at the reporting date) will be paid in instalments considering that the achievement of the certain-agreed events occur. As meeting these conditions is deemed probable, management considers such amount an adjustment of the consideration paid at the acquisition date.
Lease liabilities refer to the lease liabilities recognised following the adoption of IFRS 16.
A breakdown of other loans and borrowings at amortised cost are broken down by due date below:
| 31.12.2021 | |||||||
|---|---|---|---|---|---|---|---|
| (in Euros) | Currency | Original amount |
Maturity | Rate | Outstanding liabilities in Euros |
Current | Non current |
| MedioCredito Centrale Horizon 2020 Project |
EUR | 1,489,851 | 06/2026 | Fixed | 872,416 | 191,170 | 681,246 |
| Total | 872,416 | 191,170 | 681,246 |
The loan granted by Mediocredito Centrale refers to a research and development project accepted by the Ministry of Economic Development ("MISE") which falls within the scope of the Horizon 2020 EU framework programme.
Intragroup loans and borrowings relate to a 6-month loan obtained from Carel Australia Pty Ltd for an original amount of AUD1,250 thousand, which is tacitly renewed unless terminated by one of the parties.
The effective designated derivative hedges recognised under non-current and current financial liabilities include the fair value of IRSs signed to hedge the interest rate risk of the loans. Specifically:
| (in Euros) | |
|---|---|
| LENDER | Instrument | Notional amount |
Maturity | Negative fair value |
|---|---|---|---|---|
| BNL (BNP Paribas) loan | Interest rate swap | 30,000,000 | 21.11.2022 | 40,625 |
| BNL (BNP Paribas) loan | Interest rate swap | 20,000,000 | 30.04.2023 | 67,220 |
| UNICREDIT loan | Interest rate swap | 20,000,000 | 30.04.2023 | 41,181 |
| Total | 149,026 |
At 31 December 2021, the company has no forwards or currency options agreed to hedge commercial transactions.

The cash pooling arrangement includes the debit balances of the cash pooling account related to the cash pooling arrangements regarding the following group companies:
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Carel U.K. Ltd | 680,473 | 1,298,799 |
| Carel France s.a.s. | 2,823,758 | 371,262 |
| Carel Deutschland GmbH | 2,518,941 | 2,118,983 |
| Carel Controls Iberica Sl | 1,203,133 | 1,596,962 |
| Carel Adriatic Doo | 2,334,058 | 6,246,323 |
| HygroMatik GmbH | 5,949,037 | - |
| Recuperator S.p.A. | 33,598 | - |
| Total | 15,542,998 | 11,632,329 |
The following tables show changes in current and non-current financial liabilities, comprising lease liabilities (including cash and non-cash changes).
| (in Euros) | 31.12.2021 | Net cash flows |
Change in fair value |
Reclassification | 31.12.2020 |
|---|---|---|---|---|---|
| Bank loans and borrowings at amortised cost |
67,920,086 | 5,693,786 | - | (24,682,427) | 86,908,727 |
| Other non-current financial liabilities | 1,440,014 | 1,440,014 | - | ||
| Other non-current loans and borrowings at amortised cost |
681,246 | - | - | (191,170) | 872,416 |
| Effective designated derivative hedges | 108,401 | (292,789) | (41,744) | (135,400) | 578,334 |
| Non-current financial liabilities | 70,149,747 | 6,841,011 | (41,744) | (25,008,997) | 88,359,477 |
| (in Euros) | 31.12.2021 | Net cash flows |
Change in fair value |
Reclassification | 31.12.2020 |
|---|---|---|---|---|---|
| Bank loans and borrowings at amortised cost |
60,196,202 | (6,949,095) | - | 24,682,427 | 42,462,870 |
| Other loans and borrowings at amortised cost |
191,170 | (314,654) | - | 191,171 | 314,653 |
| Intragroup loans and borrowing at amortised cost |
800,512 | 800,512 | - | - | - |
| Effective designated derivative hedges | 40,625 | (97,109) | (410) | 135,400 | 2,744 |
| Cash pooling arrangement | 15,542,998 | 3,910,669 | - | - | 11,632,329 |
| Other financial liabilities at amortised cost | 18,733 | 18,733 | - | - | - |
| Current financial liabilities | 76,790,240 | (2,630,944) | (410) | 25,008,998 | 54,412,596 |
| 31.12.2021 | Increases | Restatement of | Repayments | Interest | Termination | 31.12.2020 | |
|---|---|---|---|---|---|---|---|
| (in Euros) | financial liabilities | of contracts | |||||
| Lease liabilities | 13,418,965 | 223,636 | (257,499) | (1,615,411) | 85,554 | (4,202) | 14,986,887 |


Changes to the non-current and current provisions for risks can be broken down as follows:
| VARIATION | |||||||
|---|---|---|---|---|---|---|---|
| (in Euros) | 31.12.2021 | Actuarial gains |
Accruals | Reversals | Utilisations | Reclassifications | 31.12.2020 |
| Provision for agents' termination benefits |
815,368 | (14,623) | 36,581 | - | - | - | 793,410 |
| Provision for product warranties |
294,733 | - | 105,671 | (33,538) | - | 222,600 | |
| Provision for commercial complaints |
- | - | - | (26,500) | - | - | 26,500 |
| Total - non-current | 1,110,101 | (14,623) | 142,252 | (26,500) | (33,538) | - | 1,042,510 |
| Provision for legal and tax risks |
- | - | - | (35,000) | (90,000) | - | 125,000 |
| Provision for commercial complaints |
1,907,436 | - | 557,165 | - | (628,622) | - | 1,978,893 |
| Total - current | 1,907,436 | - | 557,165 | (35,000) | (718,622) | - | 2,103,893 |
| Total provisions for risks |
3,017,537 | (14,623) | 699,417 | (61,500) | (752,160) | - | 3,146,403 |
The provision for agents' termination benefits, accrued for the potential risks of the termination of agency contracts, considers the estimated liabilities related to contacts in place at year end.
The provision for agents' termination benefits is calculated by an independent actuary using the closed group approach in accordance with IAS 37. The assessments were carried out by quantifying future payments through the projection of agency commissions accrued at the assessment date up to the estimated moment (uncertain) in which the contractual relationship will be terminated.
The demographic assumptions were based on the Mortality table RG48 published by the General Accounting Office, the INPS tables split by age and gender for disabilities and the requirements are set out by ENASARCO (the Italian social security foundation for business agents and representatives) for the pensionable age.
With regard to the possible termination of agency agreements by the company or for other causes, the company estimated annual termination rates of 2.50% for voluntary resignations and 2.00% for company reasons based on internal date data.
The financial assumptions, on the other hand, essentially relate to the discount rate, which, at 31 December 2021, was deemed to be in line with the Iboxx AA Corporate index with the same term as the closed group subject to assessment, equal to 0.44%.
The provision for product warranties is related to the non-current portion of the liabilities, reasonably estimated based on the guarantees contractually granted to customers and past experience, connected to costs for spare parts and labour that the company may incur in future years for assistance to be provided for products, the sales revenue of which has already been recognised in profit or loss for the year or in previous years.
The provision for commercial complaints refers to the prudent accrual for costs incurred for commercial complaints from customers related to products sold.
The provision increased due to the estimated larger costs that the company might occur on claims with customers.
The use during the year relates to specific customer complaints.

This caption consists of the company's liability for post-employment benefits and post-term of office benefits for directors. These benefits qualify as defined benefit plans pursuant to IAS 19 and the related liabilities are calculated by an independent actuary applying the closed group approach in accordance with the accrued benefits methodology using the projected unit credit method envisaged in IAS 19.
As described in the Accounting policies, the actuarial gains or losses are recognised in a specific equity reserve through other comprehensive income.
Defined benefit plans and changes therein may be analysed as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Post-employment benefits | 4,180,800 | (253,695) | 4,434,495 |
| Post-term of office benefits for directors | 788,569 | 82,290 | 706,279 |
| Total | 4,969,369 | (171,405) | 5,140,774 |
Post-employment benefits at year end were as follows:
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Opening balance | 4,434,495 | 4,626,593 |
| Accruals | 1,923,281 | 1,746,099 |
| Transfers to pension funds | (1,895,794) | (1,736,070) |
| Interest cost | 24,023 | 33,731 |
| Employee benefits paid | (352,835) | (301,985) |
| Substitute tax | (27,487) | (10,029) |
| Actuarial losses | 75,117 | 76,156 |
| Closing balance | 4,180,800 | 4,434,495 |
Law no. 296/06 changed the Italian post-employment benefits scheme and they are now classified as defined contribution plans regardless of whether the employee decides to have them transferred to the INPS treasury fund or a supplementary pension plan. Benefits vested up until 31 December 2006 continue to be recognised as part of a defined benefit plan and are subject to actuarial valuation, excluding the future salary increase component.
The post-term of office benefits for directors at year end was as follows:
| (in Euros) | 31.12.2021 | 31.12.2020 629,007 |
|
|---|---|---|---|
| Opening balance | 706,279 | ||
| Accruals | 90,060 | 95,931 | |
| Interest cost | 4,088 | 4,897 | |
| Benefits paid to directors | (23,625) | - | |
| Actuarial (gains) losses | 11,767 | (23,556) | |
| Closing balance | 788,569 | 706,279 |


For both liabilities the company also performed sensitivity analyses to assess reasonable changes in the main assumptions underlying the calculations. Specifically, it assumed an increase or decrease of 0.25% in the discount rate. The resulting change in the liability would be immaterial.
Deferred tax liabilities at 31 December 2021 were generated by the temporary differences between the carrying amount of assets and liabilities and their tax base calculated with reference to the tax rates that are expected to be enacted in the years in which the differences will reverse.
The deferred tax liabilities recognised in the separate financial statements refer to the following temporary differences:
| 31.12.2021 | 31.12.2020 | ||||
|---|---|---|---|---|---|
| (in Euros) | Tax base | Deferred taxes | Tax base | Deferred taxes | |
| Unrealised exchange differences | 226,964 | 54,471 | 297,820 | 71,477 | |
| Fair value changes on derivatives | 81,766 | 19,624 | 4,970 | 1,193 | |
| Diff. in amort/dep. calculated under IFRS/ OIC FTA |
121,839 | 33,993 | 188,696 | 52,646 | |
| Diff. in amort/dep. calculated under IFRS/ OIC 2015 |
185,666 | 51,800 | 187,914 | 52,428 | |
| Diff. in amort/dep. calculated under IFRS/ OIC 2016 |
31,389 | 8,757 | 140,197 | 39,115 | |
| Discounting of agents' termination benefits | 104,241 | 29,082 | 89,618 | 25,002 | |
| Total | 751,865 | 197,727 | 909,215 | 241,861 |
| 31.12.2021 | Recognised in profit or loss |
Recognised in other comprehensive income |
31.12.2020 | |
|---|---|---|---|---|
| (in Euros) | ||||
| Unrealised exchange differences | 54,471 | (17,006) | - | 71,477 |
| Fair value changes on derivatives | 19,624 | - | 18,431 | 1,193 |
| Diff. in amort/dep. calculated under IFRS/ OIC FTA |
33,993 | (18,653) | - | 52,646 |
| Diff. in amort/dep. calculated under IFRS/ OIC 2015 |
51,800 | (628) | - | 52,428 |
| Diff. in amort/dep. calculated under IFRS/ OIC 2016 |
8,757 | (30,358) | - | 39,115 |
| Discounting of agents' termination benefits |
29,082 | 4,080 | - | 25,002 |
| Total | 197,727 | (62,565) | 18,431 | 241,861 |

These amount to €8,057 thousand and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Third party options | 7,924,065 | 7,924,065 | - |
| Other non-current liabilities | 133,121 | 133,121 | - |
| Total | 8,057,186 | 8,057,186 | - |
Third party options relate to the fair value of the call option on the non-controlling interests in CFM. Reference should be made to note [3] Equity investments for more details.
The derivative is remeasured at each reporting date and any resulting fair value gains or losses are recognised in profit or loss. The derivative was discounted using a rate of 1.54%, held to approximate the company's cost of debt.
Its initial carrying amount of €7,985 thousand decreased by a fair value gain of €61 thousand, which was recognised as other financial income.
Other non-current liabilities relate to the cash award liability to the beneficiaries of the 2021-2025 cash-settled performance plan. For more information, reference should be made to the section on "Cash-settled and equity-settled payment arrangements" of note [33].
These amount to €52,401 thousand (€37,635 thousand at 31 December 2020) and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Payments on account to customers | 1,223,774 | 503,758 | 720,016 |
| Third parties | 30,676,461 | 6,774,383 | 23,902,078 |
| Subsidiaries | 19,935,611 | 7,074,991 | 12,860,620 |
| Associates | 454 | (55,039) | 55,493 |
| Subsidiaries of parents | 111,995 | 28,130 | 83,865 |
| Related parties | 452,548 | 439,644 | 12,904 |
| Total | 52,400,843 | 14,765,867 | 37,634,976 |
Payments on account received from customers relate to supply contracts that entail the future provision of services.
Trade payables relate to transactions with suppliers to purchase raw materials, consumables, processing and services. These activities are part of the normal procurement management. The change recognised during the year is related to the normal commercial dynamics combined with business growth.
Trade payables in foreign currency were retranslated using the closing rate, adjusting the originally-recognised amount.


Trade payables refer to the following geographical segments:
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Europe, Middle East and Africa | 39,586,558 | 31,514,447 |
| APAC | 12,045,837 | 5,832,372 |
| North America | 473,078 | 234,750 |
| South America | 295,370 | 53,407 |
| Total | 52,400,843 | 37,634,976 |
A breakdown of trade payables to group companies is as follows:
| (in Euros) | 31.12.2021 | 31.12.2020 |
|---|---|---|
| C.R.C. Srl | 7,946 | 43,361 |
| Recuperator S.p.A | 3,203 | 2,013 |
| Carel U.K. Ltd | 172,186 | 45,000 |
| Carel France Sas | 5,108 | 29,422 |
| Carel Asia Ltd | 15,255 | 13,946 |
| Carel Sud America Instrumentacao Eletronica Ltda | 217,986 | 45,482 |
| Carel Usa Llc | 75,761 | 15,027 |
| Carel Australia Pty Ltd | 27,823 | 5,120 |
| Carel Deutschland GmbH | 37,115 | 13,940 |
| Carel Electronic (Suzhou) Co Ltd | 11,615,171 | 5,455,811 |
| Carel Controls Iberica Sl | - | 2,068 |
| Carel ACR Systems India (Pvt) Ltd | 109,023 | 92,003 |
| Carel Controls South Africa (Pty) Ltd | 964 | 966 |
| Carel Rus Llc | 353,077 | 336,210 |
| Carel Korea Ltd | 9,712 | 10,311 |
| Carel Nordic AB | 397,481 | 334,660 |
| Carel Japan Co. Ltd | 3,545 | 3,038 |
| Carel Mexicana S.De.RL | 4,128 | 3,810 |
| Carel Middle East DWC Llc | 192,086 | 120,044 |
| Alfaco Polska Sp.z.o.o | - | 7,571 |
| Carel Adriatic Doo | 6,554,419 | 6,280,817 |
| HygroMatik GmbH. | 11,651 | - |
| CFM Sogutma ve Otomasyon A.S. | 121,971 | - |
| Subsidiaries | 19,935,611 | 12,860,620 |
| Arion S.r.l. | 454 | 55,493 |
| Associates | 454 | 55,493 |
| Eurotest Laboratori S.r.l. | 96,447 | 73,023 |
| Nastrificio Victor S.p.A. | 9,480 | 9,221 |
| Panther S.r.l | 6,068 | 1,621 |
| Subsidiaries of parents | 111,995 | 83,865 |
| RN Real Estate S.r.l. | 442,088 | - |
| Altre correlate minori | 10,460 | 12,904 |
| Related parties | 452,548 | 12,904 |

These amount to €51 thousand and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Tax liabilities pertaining to previous years | 50,982 | (67,976) | 118,958 |
| Total | 50,982 | (67,976) | 118,958 |
Tax liabilities pertaining to previous years relate to the payment plan, defined after the agreement of the mutually-agreed assessment settlement procedure for 2013 by the company and the Venice regional tax office following the preliminary assessment report issued in June 2018 upon conclusion of the audit into 2013, 2014, 2015 and 2016.
These amount to €14,423 thousand and can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Other tax liabilities | 1,632,367 | 150,020 | 1,482,347 |
| Social security contributions | 3,702,266 | 2,480 | 3,699,786 |
| Other liabilities | 8,148,605 | 830,029 | 7,318,576 |
| Accrued expenses and deferred income | 939,933 | 588,644 | 351,289 |
| Total | 14,423,171 | 1,571,173 | 12,851,998 |
Other tax liabilities can be broken down as follows
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Withholdings to be paid | 1,551,638 | 69,291 | 1,482,347 |
| Foreign VAT | 16,264 | 16,264 | - |
| Substitute tax on post-employment benefits | 64,465 | 64,465 | - |
| Total | 1,632,367 | 150,020 | 1,482,347 |
Social security contributions can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| INPS | 1,375,677 | (89,371) | 1,465,048 |
| Social security contributions on deferred remuneration |
1,939,330 | 261,271 | 1,678,059 |
| ENASARCO | 13,291 | 108 | 13,183 |
| Others | 91,706 | (23,201) | 114,907 |
| Pension funds | 282,262 | (146,327) | 428,589 |
| Total | 3,702,266 | 2,480 | 3,699,786 |


Other liabilities can be broken down as follows:
| (in Euros) | 31.12.2021 | Variation | 31.12.2020 |
|---|---|---|---|
| Wages and salaries | 8.075.241 | 819.923 | 7.255.318 |
| Directors' fees | 49.601 | (7.509) | 57.110 |
| Other sundry amounts | 23.763 | 17.615 | 6.148 |
| Total | 8.148.605 | 830.029 | 7.318.576 |
Wages and salaries include €6,621 thousand related to bonuses and unused holidays at 31 December 2021. The remaining amount refers to December pay.
Accrued expenses and deferred income refer to income or charges collected/paid before or after the year to which they pertain. They are recognised regardless of the payment or collection date when the related income and charges are common to two or more years and can be allocated over time.
Other deferred income refers to the accrued portion of tax assets that will be taken to profit or loss as follows:
| (in Euros) | |
|---|---|
| Year: | Amount |
| 2022 | 247,930 |
| 2023 | 211,317 |
| 2024 | 145,980 |
| 2025 | 55,593 |
| 2026 | 55,593 |
| 2027 | 55,593 |
| 2028 | 55,593 |
| 2029 | 46,845 |
| 2030 | 38,318 |
| Total | 912,762 |

A breakdown of the caption is as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Revenue from sales and services | 215,424,960 | 35,057,601 | 180,367,359 |
| Total | 215,424,960 | 35,057,601 | 180,367,359 |
Revenue from sales and services, shown net of discounts and allowances, essentially relates to the sales of products to third parties and group companies and administration-commercial-financial coordination services provided to group companies. Specifically:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Third parties | 118,185,602 | 19,748,408 | 98,437,194 |
| Intragroup | 97,239,358 | 15,309,193 | 81,930,165 |
| Total | 215,424,960 | 35,057,601 | 180,367,359 |
Reference should be made to the disclosures on related party transactions provided in note [33] for a breakdown of revenue from subsidiaries.
In line with the rise in sales to third parties, intragroup sales were pushed up by the internal demand of the countries in which the group companies operate as distributors.
Revenue from sales of goods and services to third parties amounts to €118,186 thousand, up on €98,437 thousand in 2020. A breakdown of revenue by business segment is as follows:
| (in Euros) | 2021 | 2020 |
|---|---|---|
| HVAC revenue | 75,889,227 | 62,383,707 |
| REF revenue | 40,482,412 | 34,606,204 |
| Non-core revenue | 1,813,963 | 1,447,283 |
| Total | 118,185,602 | 98,437,194 |
Revenue from sales and services may be broken down by geographical segment as follows:
| (in Euros) | 2021 | "Breakdown %" |
2020 | "Breakdown %" |
|---|---|---|---|---|
| Europe, Middle East and Africa | 184,843,569 | 85.80% | 153,506,140 | 85.11% |
| APAC | 16,951,305 | 7.87% | 15,689,687 | 8.70% |
| Nord America | 9,858,393 | 4.58% | 8,297,769 | 4.60% |
| Sud America | 3,771,693 | 1.75% | 2,873,763 | 1.59% |
| Totale | 215,424,960 | 100.00% | 180,367,359 | 100.00% |
An analysis of the revenue trend analysis is provided in the directors' report.


| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Grants related to income | 1,413,676 | 536,987 | 876,689 |
| Licence fees | 4,026,106 | 1,912,078 | 2,114,028 |
| Sundry cost recoveries | 1,840,908 | 436,412 | 1,404,496 |
| Compensation | 8,097 | (11,257) | 19,354 |
| Company canteen cost recovery | 90,205 | 26,753 | 63,452 |
| Other revenue and income | 69,071 | (120,721) | 189,792 |
| Total | 7,448,063 | 2,780,252 | 4,667,811 |
Grants related to income relate to the tax assets accrued during the year ("Industry 4.0 – Law no. 160/2019"; "Maxi-depreciation – Law no. 178/2020"; "Ecobonus – Law no. 296/2006"; and "Tax credit for research and development activities – Law no. 178/2020") and taken to profit or loss based on the relevant expense caption. Licence fees relate to royalties only received from group companies.
Sundry cost recoveries mainly relate to the reimbursement of transport costs by third parties and group companies.
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Purchases of raw materials, supplies and goods | (119,526,712) | (26,223,014) | (93,303,698) |
| Purchases of consumables | (1,639,170) | (242,468) | (1,396,702) |
| Change in raw materials and goods | 5,574,043 | 4,577,890 | 996,153 |
| Change in finished goods and semi-finished products | 779,611 | 1,492,517 | (712,906) |
| Total | (114,812,228) | (20,395,075) | (94,417,153) |
Costs of raw materials, consumables and goods refer to goods purchased for the company's normal production activities and can be broken down as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Purchases of raw materials and semi-finished goods | (60,712,524) | (14,084,919) | (46,627,605) |
| Purchases of goods held for resale | (56,281,775) | (11,644,274) | (44,637,501) |
| Purchases of other materials | (2,760,446) | (616,963) | (2,143,483) |
| Total | (119,754,745) | (26,346,156) | (93,408,589) |
| Returns, markdowns, bonuses and discounts | 228,033 | 123,142 | 104,891 |
| Total purchases of raw materials, consumables, supplies and goods |
(119,526,712) | (26,223,014) | (93,303,698) |

The intragroup purchases of raw materials, consumables, supplies and goods amount to €47,967 thousand in 2021 (€38,114 thousand in 2020).
The increase in costs for raw materials, consumables, supplies and goods is proportionate to the sales trend and the rise in the price of raw materials used in the various production cycles due to inflation and shortages, which had an adverse affect especially in the second half of the year.
The change in raw materials and goods refers to the acquisition of goods that will mostly be transformed rather than used, net of write-downs made to reflect obsolescence and the reduced usability of the products.
The change in finished goods and semi-finished products can be broken down as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Work in progress | (83,854) | (275,680) | 191,826 |
| Semi-finished goods | 3,317 | (367,580) | 370,897 |
| Finished goods | 860,148 | 2,135,777 | (1,275,629) |
| Total | 779,611 | 1,492,517 | (712,906) |
A breakdown of the caption is as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Services | (29,205,079) | (3,633,838) | (25,571,241) |
| Use of third party assets | (924,995) | (214,896) | (710,099) |
| Total | (30,130,074) | (3,848,734) | (26,281,340) |
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Agency contracts | (5,020,382) | (345,440) | (4,674,942) |
| Transport | (4,864,205) | (465,564) | (4,398,641) |
| Consultancies | (4,231,399) | (1,428,740) | (2,802,659) |
| Maintenance and repairs | (4,072,132) | (980,628) | (3,091,504) |
| Outsourcing | (3,878,921) | 524,894 | (4,403,815) |
| Fees to directors, statutory auditors and independent auditors |
(1,586,121) | (126,746) | (1,459,375) |
| Personnel expense and temporary staff | (1,194,886) | (412,170) | (782,716) |
| Other services | (1,060,023) | (232,020) | (828,003) |
| Certifications | (1,051,003) | (232,529) | (818,474) |
| Utilities | (756,983) | (97,086) | (659,897) |
| Insurance | (715,107) | (61,567) | (653,540) |
| Telephone and connections | (273,563) | 15,185 | (288,748) |
| Marketing and advertising | (268,547) | 244,926 | (513,473) |
| Business trips and travel | (231,807) | (36,353) | (195,454) |
| Total | (29,205,079) | (3,633,838) | (25,571,241) |


Almost all service costs increased over the previous year. The main increases related to consultancies for mergers and acquisitions, maintenance and repairs for the use of software licences and temporary work. However, the latter increase translated into a reduction of outsourcing costs.
Intragroup services totalled €5,800 thousand (€5,092 thousand in 2020), including agency and sales assistance services of €4,203 thousand, transport and shipping services of €425 thousand and administrative services of €373 thousand.
Finally, during the year, the company incurred costs for non-recurring services of €1,358 thousand related to assistance with mergers and acquisitions.
A breakdown of costs for the use of third party assets is as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Car lease payments | (259.994) | 7.855 | (267.849) |
| Royalties on patents and trademarks | (276.275) | (143.084) | (133.191) |
| Other payments for the use of third party assets | (388.726) | (79.667) | (309.059) |
| Total | (924.995) | (214.896) | (710.099) |
Car lease payments mainly include the related ancillary costs.
Other payments for the use of third party assets mostly relate to the lease of internal means of transport and electronic office equipment which are exempted from the application of IFRS 16 as they are short-term or low value leases.
Building leases relate entirely to group companies.
This caption refers to expenditure for the year related to development projects capitalised under intangible assets and amortised over five years for projects completed by the reporting date or recognised as assets under development if not yet completed. The remainder relates to equipment and machinery constructed internally and recognised under property, plant and equipment.
A breakdown of the caption is as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Development expenditure | 837,231 | (995,171) | 1,832,402 |
| Self-constructed industrial and commercial equipment | 49,760 | 25,603 | 24,157 |
| Total | 886,991 | (969,568) | 1,856,559 |

| (valori in Euro) | 2021 | Variation | 2020 |
|---|---|---|---|
| Wages and salaries | (35,013,050) | (3,508,685) | (31,504,365) |
| Social security contributions | (9,543,288) | (621,251) | (8,922,037) |
| Defined benefit plans | (1,943,936) | (197,837) | (1,746,099) |
| Total | (46,500,274) | (4,327,773) | (42,172,501) |
Wages and salaries include the entire personnel expense for employees, including merit increases, equitysettled and cash-settled payment arrangements, promotions, unused holidays and accruals based on laws and national labour agreements. €2,353 thousand relates to temporary staff (€1,475 thousand in 2020).
Social security contributions refer to social insurance and supplementary contributions, net of exemptions, and accident insurance. The increase is directly related to changes in wages and salaries.
Defined benefit plans relate to the service cost accrued under IAS 19.
The workforce at 31 December 2021 and changes therein during the year were as follows:
| Position | 31.12.2020 | Hires | Departures | Promotions | 31.12.2021 | 2021 average |
2020 average |
|---|---|---|---|---|---|---|---|
| Managers | 27 | - | (2) | 2 | 27 | 25 | 27 |
| Junior managers | 59 | - | (1) | 1 | 59 | 60 | 55 |
| White collars | 370 | 48 | (35) | (3) | 380 | 381 | 376 |
| Blue collars | 226 | 8 | (3) | - | 231 | 212 | 227 |
| Total | 682 | 56 | (41) | - | 697 | 678 | 685 |


A breakdown of the caption is as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Gains on the sale of non-current assets | 72.401 | 69.048 | 3.353 |
| Contingent assets | 527.659 | (850.511) | 1.378.170 |
| Other income | 600.060 | (781.463) | 1.381.523 |
| Losses on the sale of non-current assets | (1.483) | 365 | (1.848) |
| Contingent liabilities | (127.691) | 131.271 | (258.962) |
| Other taxes and duties | (117.688) | (14.607) | (103.081) |
| Impairment losses on loans and receivables | (290.946) | (208.782) | (82.164) |
| Accrual to the provisions for risks | (662.837) | 627.150 | (1.289.987) |
| Membership fees | (158.769) | 11.052 | (169.821) |
| Indemnities and compensation | (154) | 5.200 | (5.354) |
| Other costs | (4.704) | 4.254 | (8.958) |
| Other expense | (1.364.272) | 555.903 | (1.920.175) |
| Other expense, net | (764.212) | (225.560) | (538.652) |
Prior year income relates to the non-existent expense and the recognition of income pertaining to previous years, €460 thousand of which is taxable and €68 thousand is not taxable.
Prior year expense relates to the non-existent income and the recognition of expense pertaining to previous years.
The accruals to the provisions for risks relate to the prudent accrual for costs to be incurred for complaints from customers about products sold for €557 thousand.
A breakdown of the caption is as follows:
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Amortisation | (3.890.235) | (116.869) | (3.773.366) |
| Depreciation | (4.634.921) | (163.634) | (4.471.287) |
| Total | (8.525.156) | (280.503) | (8.244.653) |
Depreciation includes €1,435 thousand (2020: €1,427 thousand) related to the right-of-use assets recognised under property, plant and equipment following the adoption of IFRS 16.
Reference should be made to that set out in the Accounting policies for information about amortisation, depreciation and impairment losses.

| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Income from investments in subsidiaries | 9,139,818 | (5,804,468) | 14,944,286 |
| Interest on loans granted to subsidiaries | 100,006 | 84,417 | 15,589 |
| Other financial income | 91,679 | 5,316 | 86,363 |
| Financial income | 9,331,503 | (5,714,735) | 15,046,238 |
| Interest and other financial expense to subsidiaries | (113,959) | (67,540) | (46,419) |
| Interest and other financial expense to others | (1,418,579) | (319,292) | (1,099,287) |
| Financial expense | (1,532,538) | (386,832) | (1,145,706) |
| Net financial expense | 7,798,965 | (6,101,567) | 13,900,532 |
Income from investments in subsidiaries refers to dividends resolved and received during the year amounting to:
Interest on loans granted to subsidiaries relates to interest accrued on the loan granted to Recuperator S.p.A. Reference should be made to note [4] Other non-current assets for more details on the loan.
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| "Interest income from securities classified as current assets which are not equity investments" |
17,788 | (26,026) | 43,814 |
| Interest income from cash pooling with subsidiaries | 12 | (11,892) | 11,904 |
| Bank interest income | 5,344 | 2,410 | 2,934 |
| Gains on derivatives | 68,372 | 40,661 | 27,711 |
| Other interest income | 163 | 163 | - |
| Total | 91,679 | 5,316 | 86,363 |


Equity investment for more details.
Interest and other financial expense to subsidiaries mainly refer to interest accrued on the cash pooling account overrun in place with group companies.
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Interest and other financial expense on current bank loans and borrowings |
(47) | 573 | (620) |
| Interest and other financial expense on non-current bank loans and borrowings |
(851,735) | 66,103 | (917,838) |
| Losses on forwards | (10,500) | 8,600 | (19,100) |
| Lease interest expense | (219,108) | (184,569) | (34,539) |
| Losses on derivatives | (44,079) | (44,079) | - |
| Discounting expense on liabilities | (28,112) | 10,517 | (38,629) |
| Bank charges and fees | (264,271) | (176,157) | (88,114) |
| Other interest expense | (727) | (280) | (447) |
| Total financial expense | (1,418,579) | (319,292) | (1,099,287) |
| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Realised exchange gains | 1,482,570 | 338,976 | 1,143,594 |
| Unrealised exchange gains | 314,498 | 8,054 | 306,444 |
| Exchange gains | 1,797,068 | 347,030 | 1,450,038 |
| Realised exchange losses | (1,044,279) | 114,117 | (1,158,396) |
| Unrealised exchange losses | (605,472) | 114,232 | (719,704) |
| Exchange losses | (1,649,751) | 228,349 | (1,878,100) |
| Net exchange gains (losses) | 147,317 | 575,379 | (428,062) |
| Net realised exchange gains (losses) | 438,291 | 453,093 | (14,802) |
| Net unrealised exchange gains (losses) | (290,974) | 122,286 | (413,260) |
Exchange gains and losses are part of the company's normal performance.
Unrealised exchange gains and losses mainly relate to the US dollar, the Japanese yen and the Polish zloty.
Net unrealised exchange losses totalled €291 thousand (net unrealised exchange losses of €413 thousand in 2020).

Since the company reported net unrealised exchange losses in 2021, it was not required to recognise an undistributable equity reserve as per article 2426.8-bis of the Italian Civil Code.
Net impairment gains of €957 thousand relate to:
Note [3] provides more details about the effects of equity-accounting.


| (in Euros) | 2021 | Variation | 2020 |
|---|---|---|---|
| Current taxes | (2,809,828) | 2,209,144 | (5,018,972) |
| Substitute tax | (1,962,649) | (1,962,649) | - |
| Change in deferred tax assets | 102,786 | (121,213) | 223,999 |
| Change in deferred tax liabilities | 62,565 | (1,991) | 64,556 |
| Prior year taxes | (5,782) | (206,589) | 200,807 |
| Total | (4,612,908) | (83,298) | (4,529,610) |
With regard to deferred taxes, reference should be made to the Accounting policies and the information provided about deferred tax assets (note 5) and deferred tax liabilities (note 16).
| (in Euros) | 2021 | 2020 |
|---|---|---|
| Profit before tax | 31,931,355 | 25,425,528 |
| Theoretical IRES | 7,663,525 | 6,102,127 |
| Lower taxes: | ||
| - ACE | (177,280) | - |
| - contingent assets | (16,272) | (168,455) |
| - personnel expense and supplementary pension funds | (74,778) | (46,100) |
| - dividends from equity investments and gains on the sale of investments | (2,095,879) | (3,407,297) |
| - maxi-depreciation and hyper-depreciation | (282,713) | (330,107) |
| - amortisation of goodwill | (2,957,526) | (4,066) |
| - impairment gain on equity investments | (229,681) | (115,190) |
| - patent box | - | (211,004) |
| - use of provisions for risks and charges | (180,518) | (59,071) |
| - tax asset on research and development | (338,994) | (208,531) |
| - other | (187,620) | (98,241) |
| Higher taxes: | ||
| - undeductible amortisation/depreciation | 89,516 | 127,024 |
| - accruals to provisions | 169,704 | 187,795 |
| - contingent liabilities | 7,214 | 2,380 |
| - impairment loss on equity investments | - | 903,440 |
| - write-down of inventories | 115,316 | 155,585 |
| - other undeductible costs | 84,396 | 65,939 |
| - other | 163,130 | 119,381 |
| - unused tax withholdings | 440,733 | 1,250,043 |
| - substitute tax | 1,962,649 | - |
| Total income taxes (IRES) | 4,154,922 | 4,265,652 |
| IRAP | 617,555 | 753,320 |
| Prior year taxes | 5,782 | (200,807) |
| Deferred taxes | (165,351) | (288,555) |
| TOTAL INCOME TAXES | 4,612,908 | 4,529,610 |

2021 was blighted by the persisting Covid-19 pandemic in almost all areas of the world where the group operates, though with varying intensity depending on the region. All plants and commercial companies were operating during the year and there were no significant disruptions to the supply chain.
Though not directly linked to how the pandemic unfolds, the group is closely monitoring global price trends and availability of certain raw materials used in the different production processes, specifically semiconductors and aluminium. In line with measures adopted in the previous year, it rolled out processes to procure supplies from various sources in order to mitigate the risk of shortages or excessive purchase price fluctuations.
Finally, for an overview of the effects of the pandemic on the company's and group's markets, reference should be made to the directors' report.
The application for renewal of the scheme for 2020 and following four years presented in October 2019 and repeated when filing the 2020 tax return is still pending with the relevant regional tax office to date.
The 2018-2022 equity-settled performance plan resolved by the shareholders on 7 September 2018 is an equity-settled incentive plan, with the free assignment of shares to members of boards of directors and/or company employees. The plan is divided into three rolling cycles (vesting periods), each lasting three years (2018-2020, 2019-2021 and 2020-2022), at the end of which the shares will be distributed, after checking that the performance objectives have been reached and based on the date of the board of directors' resolution.
The number of shares assigned is subject to achieving performance objectives based on adjusted EBITDA and cash conversion ratios. The performance objectives are independent of one another and will be calculated separately for each vesting period.
On 4 March 2021, the company's board of directors approved the assignment of treasury shares upon conclusion of the first rolling cycle (2018-2020). It has granted 68,798 rights with a fair value of €691 thousand on 1 October 2018 for this vesting period.
In April 2021, it assigned 67,688 treasury shares to 12 beneficiaries for a total of €657 thousand. The gain of €34 thousand between the fair value of the shares assigned, measured using the rolling FIFO method, and their fair value at the grant date was reclassified to an available income-related reserve.
On 4 March 2021, the company's board of directors also approved:
The term, vesting periods, beneficiaries and performance objectives (cumulative adjusted EBITDA for each vesting period (weight of 50%), cash conversion - average value of the vesting periods (weight of 30%), ESG targets - average achievement of a number of sustainability indicators (weight of 20%)) are the same for both plans.
On 20 April 2021, the company's shareholders approved the 2021-2025 equity-settled performance plan for


the free assignment of shares to the members of the boards of directors and/or employees, as described earlier.
Finally, on 4 November 2021, the company's board of directors resolved in favour of the 2021-2025 cashsettled performance plan rather than the 2021-2025 equity-settled performance plan, as the allocation of awards under the former plan is simpler for both the company and the beneficiaries, given that assigning the shares under the latter may pose complex operating issues, even through both plans have the same characteristics, the same terms and conditions and the same performance conditions. Again in November, the company delivered the award acceptance letter to the beneficiaries.
On the same date, the board of directors identified the beneficiaries of the 2021-2025 cash-settled performance plan for the first vesting period (2021-2023) and established the percentage of their base gross annual remuneration to be received as a cash benefit for each one. Such incentives total approximately €1,720 thousand.
The cash to be actually paid to each beneficiary will be calculated at the end of the 2021-2023 vesting period considering whether they have met the performance conditions established in the plan's regulation.
In accordance with IFRS 2 Share-based payment, the fair value of the distributions calculated at the allocation date applying the Black-Scholes method is recognised in profit or loss as personnel/directors expense, on a systematic basis over the vesting period with a balancing entry in equity.
In 2021, the company recognised an expense of €818 thousand in profit or loss and the same amount was also recognised as an increase in equity. This amount represents the amount attributable to:
Pursuant to IAS 19 Employee benefits, cash-settled incentive plans qualify as defined benefit plans and, therefore, the liability was calculated by an independent actuary using the projected unit credit method as required by the standard. This method determines the average present value of the obligations accrued for the service provided by the beneficiary up to the valuation date.
The company recognised a cost of €133 thousand in profit or loss in 2021 and a similar amount under Other non-current liabilities at 31 December 2021 as provided for in the cash-settled performance plan.
On 20 April 2021, the shareholders resolved, inter alia, to authorise the board of directors to dispose of treasury shares already repurchased in line with previous authorisations and to be repurchased for the purposes of:
The repurchase of treasury shares can take place in one or more transactions of up to a maximum of 5,000,000 shares, equal to 5% of the company's share capital, within the limits of its distributable profits and the available reserves as shown in the most recently approved financial statements, over a period of 18 months from the date of the meeting.

In April 2021, the company assigned 67,688 treasury shares for a total of €657 thousand upon conclusion of the first vesting period (2018-2020) for rights assigned on 1 October 2018.
The company did not repurchase any treasury shares during the year.
At the reporting date, the company had repurchased 100,521 treasury shares, equal to 0.1005% of its share capital, for a total of €1,104 thousand.
Under IFRS 8, an entity shall disclose information to enable users of its financial statements to evaluate the nature and financial effects of the business activities in which it engages and the economic environments in which it operates. Based on the company's internal reporting system, the business activities from which it earns revenue and incurs expenses and the operating results which are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated and to assess its performance, the company has not identified individual operating segments but is an operating segment as a whole.
e fees paid, net of expenses, to directors, statutory auditors and key management personnel during the year were as follows:
| (in Euros) | 2021 | 2020 |
|---|---|---|
| Directors | ||
| - Remuneration and fees | 1,445,000 | 1,256,378 |
| - Other non-monetary benefits | 23,039 | 16,198 |
| - Fair value of share-based payments | 174,934 | 307,989 |
| Total directors | 1,642,973 | 1,580,565 |
| Statutory auditors | ||
| - Fixed fees and fees for participation in committees | 90,000 | 90,000 |
| Total statutory auditors | 90,000 | 90,000 |
| Key management personnel | ||
| - Remuneration and fees | 1,337,809 | 1,170,643 |
| - Other non-monetary benefits | 21,263 | 21,538 |
| - Fair value of share-based payments | 181,530 | 318,357 |
| - Post-term of office benefits or termination benefits (2) | - | 26,069 |
| Total key management personnel | 1,540,602 | 1,536,607 |
(2) cash outflow


The following table highlights the fees pertaining to the year for audit and non-audit services provided by the independent auditors:
| (in Euros) | 2021 | 2020 |
|---|---|---|
| Audit | 238,310 | 204,750 |
| Attestation services | 44,000 | 41,000 |
| Total | 282,310 | 245,750 |
(Annual market and competition law)
A list of the subsidies, grants, fees for paid positions and any type of economic benefits received from public administrations and other parties defined by article 1.125 of Law no. 124 of 2017, that the company received in 2021 is set out below, in addition to the portion pertaining to the year of the tax credit for research, development and innovation activities and the "Industry 4.0" tax credit:
At the reporting date, the company has issued sureties of €1,627 thousand, including €213 thousand in favour of subsidiaries.
In order to limit the administrative requirements for some investees, the company has acted as guarantor of the liabilities to third parties recognised in the financial statements of the subsidiaries Carel Deutschland GmbH and HygroMatik GmbH, as required by applicable local regulations.

A breakdown of the indirect investees at 31 December 2021 is as follows:
| (in Euros) | Registered office | Parent |
|---|---|---|
| Subsidiaries: | ||
| Enginia Srl | Trezzo Sull'Adda-IT | Recuperator S.p.A. |
| Carel Australia Pty. Ltd | SYDNEY-AU | Carel Electronic (Suzhou) Co Ltd |
| Carel Electronic (Suzhou) Co Ltd | ||
| Carel ACR Systems India (Pvt) Ltd | MUMBAI-IN | Carel France s.a.s. |
| Carel Controls South Africa (Pty) Ltd | JOHANNESBURG-ZA | Carel Electronic (Suzhou) Co Ltd |
| Carel HVAC&R Korea Ltd | SEOUL-KR | Carel Electronic (Suzhou) Co Ltd |
| Carel South East Asia Pte. Ltd. | SINGAPORE-SG | Carel Asia Ltd |
| Carel Mexicana S.De.RL | Guerra, Tlalpan-MX | Carel Usa Llc |
| BANGKOK-TH | Carel Electronic (Suzhou) Co Ltd | |
| Carel (Thailand) CO Ltd | Carel Australia Pty. Ltd | |
| Carel Ukraine Llc | Kiev-UA | Alfaco Polska Sp.z.o.o. |
| Enersol Inc | Beloeil (Quebec)-CA | Carel Usa Llc |
In order to satisfy the disclosure requirement of article 2427.1.22-bis of the Italian Civil Code, we note the following:
The table below provides assets, liabilities, revenue and costs related to transactions with related parties performed in 2021.
| 31.12.2021 | Assets and liabilities | |||
|---|---|---|---|---|
| (in Euros) | Loan assets | "Trade receivables/ Other assets" |
Financial liabilities |
"Trade payables/ Other liabilities" |
| Subsidiaries | ||||
| C.R.C S.r.l. | 500,167 | 141,357 | - | 7,946 |
| Recuperator S.p.A | 14,404,493 | 136,895 | 33,598 | 3,203 |
| Enginia S.r.l. | - | 68 | - | - |
| Carel U.K. Ltd | - | 1,273,582 | 680,473 | 172,186 |
| Carel France s.a.s. | - | 1,916,828 | 2,823,758 | 5,108 |
| Carel Asia Ltd | - | 1,470,682 | - | 15,255 |
| Carel Sud America Instrumentacao Eletronica Ltda | - | 848,184 | - | 217,986 |
| Carel Usa Llc | - | 2,896,974 | - | 75,761 |


Indirect investees
Related party transactions
individual companies involved;
following:
conditions.
performed in 2021.
A breakdown of the indirect investees at 31 December 2021 is as follows:
In order to satisfy the disclosure requirement of article 2427.1.22-bis of the Italian Civil Code, we note the
a. intragroup and related party transactions performed during the year gave rise to commercial, financial and consulting relationships and were carried out on an arm's-length basis, in the economic interests of the
b. the interest rates and conditions applied to intragroup financial transactions are in line with market
The table below provides assets, liabilities, revenue and costs related to transactions with related parties
| Indirect investment | Profit (loss) for the year (Euros) |
Equity (deficit) (Euros) | Share capital (foreign currency) |
Currency |
|---|---|---|---|---|
| 100.00% | 898,967 | 5,915,467 | 10,400 | EUR |
| 100.00% | 646,691 | 4,024,542 | 100 | AUD |
| 99.99% | ||||
| 0.01% | 250,282 | 1,086,383 | 1,665,340 | INR |
| 100.00% | 752,573 | 1,980,972 | 4,000,000 | ZAR |
| 100.00% | (259,795) | 65,583 | 550,500,000 | KRW |
| 100.00% | 47,340 | 370,904 | 100,000 | SGD |
| 100.00% | 31,270 | 779,344 | 12,441,149 | MXN |
| 79.994% | ||||
| 0.006% | 200,803 | 1,695,361 | 16,000,000 | THB |
| 100.000% | 84,397 | (74,929) | 700,000 | UAH |
| 100.000% | 267,595 | 400,311 | 100 | CAD |
| Revenue and costs | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sale of services |
Other revenue |
Purchases of goods and materials |
Services | Other purchases |
Income from equity investments |
Financial income |
Financial expense |
|
| 29,331 | 5,292 | 44,442 | 320 | - | - | 167 | - | |
| - | 148,000 | 208,883 56 |
- - |
488 - |
- - |
- - |
99,840 - |
9,624 - |
| 251,909 | 43,161 | 111,384 | 345,558 | - | - | - | 6,239 | |
| 31,659 | 327,284 | 1,016 | - | - | - | - | 11,682 | |
| 13,386 | 1,175 | 22,775 | - | - | - | - | - | |
| 65,994 | 2,312 | 363,341 | 118,831 | - | - | - | - | |
| 254,050 | 671,552 | 162,263 | 168,878 | - | 1,665,695 | - |

| 31.12.2021 | Assets and liabilities | |||
|---|---|---|---|---|
| (in Euros) | Loan assets | "Trade receivables/ Other assets" |
Financial liabilities |
"Trade payables/ Other liabilities" |
| Carel Australia Pty. Ltd | - | 3,708 | 801,780 | 27,823 |
| Carel Deutschland GmbH | - | 1,172,199 | 2,518,941 | 37,115 |
| Carel Electronic (Suzhou) Co Ltd | - | 3,359,386 | - | 11,615,171 |
| Carel Controls Iberica S.L. | - | 1,861,308 | 1,203,133 | - |
| Carel ACR Systems India (Pvt) Ltd | - | 695,223 | - | 109,023 |
| Carel Controls South Africa (Pty) Ltd | - | 12,367 | - | 964 |
| Carel Rus Llc | - | 97,807 | - | 353,077 |
| Carel Korea Ltd | - | 83,000 | - | 9,712 |
| Carel Nordic AB | - | 2,500 | - | 397,481 |
| Carel Japan Co. Ltd | - | 37,375 | - | 3,545 |
| Carel Mexicana S.De.RL | - | 133,944 | - | 4,128 |
| Carel Middle East DWC Llc | - | 82,056 | - | 192,086 |
| Alfaco Polska Sp.z.o.o. | 612 | 1,344,648 | - | - |
| Carel Adriatic d.o.o. | - | 2,865,234 | 2,334,058 | 6,554,419 |
| HygroMatik GmbH | - | 3,352 | 5,949,037 | 11,651 |
| CFM Sogutma Ve Otomasyon | - | 839,885 | - | 121,971 |
| Total subsidiaries | 14,905,272 | 21,278,562 | 16,344,778 | 19,935,611 |
| Associates | ||||
| Arion S.r.l. | 160,000 | - | - | 454 |
| Total associates | 160,000 | - | - | 454 |
| Subsidiaries of parents | ||||
| Eurotest Laboratori S.r.l. | - | 5,807 | - | 96,447 |
| Arianna S.p.A. | - | 4,575 | - | - |
| Nastrificio Victor S.p.A. | - | - | - | 9,480 |
| Panther S.r.l. | - | - | - | 6,068 |
| Total subsidiaries of parents | - | 10,382 | - | 111,995 |
| Related parties | ||||
| RN Real Estate S.r.l. | - | 12,444 | 12,885,160 | 442,088 |
| Other, minor | - | 1,713 | 1,440,014 | 10,460 |
| Total related parties | - | 14,157 | 14,325,174 | 452,548 |
| TOTAL | 15,065,272 | 21,303,101 | 30,669,952 | 20,500,608 |


| Revenue and costs | ||||||||
|---|---|---|---|---|---|---|---|---|
| Financial expense |
Financial income |
Income from equity investments |
Other purchases |
Services | Purchases of goods and materials |
Other revenue |
Sale of services |
Sale of products |
| 13,188 | - | - | 4,810 | 7,294 | 2,475 | - | 7,077 | - |
| 17,574 | - | 1,000,000 | - | 26,894 | 51,516 | 383,961 | 73,961 | 20,753,325 |
| - | 2,485,554 | - | 391,071 | 16,616,281 | 1,558,077 | 544,265 | 6,582,274 | |
| 7,913 | - | 500,000 | - | - | 83 | 161,330 | 48,015 | 9,544,200 |
| - | - | - | 241,334 | - | - | 6,066 | 824,694 | |
| - | - | - | - | - | 60 | 11,000 | 99 | |
| - | 491,500 | - | 1,451,190 | 910 | 1,860 | 163,127 | 404,778 | |
| - | - | - | - | 5,404 | - | 14,105 | 541,410 | |
| - | - | - | 1,436,168 | - | 1,799 | 10,098 | 8,633 | |
| - | - | - | - | 1,297 | - | 230 | 160,271 | |
| - | - | - | - | - | 50 | - | 342,767 | |
| - | - | - | 713,761 | - | 126 | 164,122 | 1,050 | |
| 12 | 994,629 | - | - | 112 | 1,466 | 36,867 | 8,987,020 | |
| 31,903 | - | 2,002,440 | 19,503 | 424,174 | 28,696,459 | 1,882,850 | 577,380 | 6,797,705 |
| 15,837 | - | - | - | 1,029 | 4,110 | 47,997 | 16,152 | 662,044 |
| - | - | - | 96,960 | 18,778 | 970 | 3,214 | 1,058,011 | |
| 113,960 | 100,019 | 9,139,818 | 24,313 | 5,423,950 | 46,102,646 | 5,300,261 | 2,470,008 | 94,727,774 |
| - | - | - | 7,200 | 2,080,680 | 611 | - | 270 | |
| - | - | - | 7,200 | 2,080,680 | 611 | - | 270 | |
| - | - | 742 | 327,907 | - | 2,152 | 31,000 | 308 | |
| - | - | - | - | - | - | 5,000 | - | |
| - | - | - | - | 70,788 | - | - | - | |
| - | - | - | - | 7,786 | - | - | - | |
| - | - | 742 | 327,907 | 78,574 | 2,152 | 36,000 | 308 | |
| 192,952 | - | - | - | - | - | 148,664 | 5,000 | - |
| - | - | - | 41,067 | 3,278 | 1,713 | - | - | |
| 192,952 | - | - | - | 41,067 | 3,278 | 150,377 | 5,000 | - |
| 306,912 | 100,019 | 9,139,818 | 25,055 | 5,800,124 | 48,265,178 | 5,453,401 | 2,511,008 | 94,728,352 |

The first few months of 2022 were still impacted by the lasting pandemic in many of the company's markets. However, the measures put in place by the company ensured that ordinary production activities could continue at all sites.
Management is carefully observing developments in the Russia-Ukraine conflict. The company works in the areas affected solely as a distributor and its volumes qualify as low single digit considering its revenue as a whole.
Demand for the company's applications continued to be strong in the first few months of 2022 despite the lingering presence of Covid-19 and inflationary pressures which could significantly affect households and hold back growth. In addition, the scarcity of raw materials and electronic materials seen throughout 2021 continues to be an issue although its severity cannot yet be defined.
This generalised uncertainty is exasperated by the recent international tensions surrounding the conflict between Russia and Ukraine, which could have very worrying repercussions on the European and global economies.
The company is carefully observing developments in the Russia-Ukraine conflict. It works in Russia solely as a distributor and its volumes qualify as mid single digit considering its revenue as a whole.
Dear shareholders,
Carel Industries S.p.A.'s separate financial statements as at and for the year ended 31 December 2021 show a profit of €27,318,447.
It should be noted that:
We invite you to approve the separate financial statements:
Francesco Nalini
________________________________ CEO


________________________________ ________________________________
Brugine, 3 March 2022
Chief executive officer Manager in charge of financial reporting
Francesco Nalini Nicola Biondo



Annexes to the separate financial statements as at and for the year ended
at 31 December 2021

Via N. Tommaseo, 78/C int. 3 35131 Padova Italia
Tel: +39 049 7927911 Fax: +39 049 7927979 www.deloitte.it
To the Shareholders of Carel Industries S.p.A.
We have audited the financial statements of Carel Industries S.p.A. (the "Company"), which comprise the statement of financial position as at 31 December 2021, and the statement of comprehensive income, statement of changes in equity and statement of cash flows for the year then ended, and notes to the financial statements, including a summary of significant accounting policies.
In our opinion, the accompanying financial statements give a true and fair view of the financial position of the Company as at 31 December 2021, and of its financial performance and its cash flows for the year then ended in accordance with International Financial Reporting Standards as adopted by the European Union and the requirements of national regulations issued pursuant to art. 9 of Italian Legislative Decree no. 38/05.
We conducted our audit in accordance with International Standards on Auditing (ISA Italia). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the ethical requirements applicable under Italian law to the audit of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current period. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
Ancona Bari Bergamo Bologna Brescia Cagliari Firenze Genova Milano Napoli Padova Parma Roma Torino Treviso Udine Verona
Sede Legale: Via Tortona, 25 - 20144 Milano | Capitale Sociale: Euro 10.328.220,00 i.v. Codice Fiscale/Registro delle Imprese di Milano Monza Brianza Lodi n. 03049560166 - R.E.A. n. MI-1720239 | Partita IVA: IT 03049560166
Il nome Deloitte si riferisce a una o più delle seguenti entità: Deloitte Touche Tohmatsu Limited, una società inglese a responsabilità limitata ("DTTL"), le member firm aderenti al suo network e le entità a esse correlate. DTTL e ciascuna delle sue member firm sono entità giuridicamente separate e indipendenti tra loro. DTTL (denominata anche "Deloitte Global") non fornisce servizi ai clienti. Si invita a leggere l'informativa completa relativa alla descrizione della struttura legale di Deloitte Touche Tohmatsu Limited e delle sue member firm all'indirizzo www.deloitte.com/about. © Deloitte & Touche S.p.A.


Description of the key audit matter Carel Industries financial statements as at 31 December 2021, include in "Equity investments" the investments in Recuperator S.p.A., Hygromatik GmbH and CFM Sogutma ve Otomasyon Anonim Sirketi (CFM Sogutma) for an amount respectively of Euro 22 million, Euro 57,2 million and Euro 26,5 million.
As required by IAS 36 "impairment of assets", the Directors identified potential loss indicator in consideration of the persistence of Covid 19 pandemic, which, as in the previous financial year, has been identified as "trigger event", and as a consequence they performed the impairment test as at 31 December 2021, in order to test the carrying values related to the equity investments.
In the disclosure, the Directors explain the main assumptions applied in performing the test and provide the break-even analysis in relation to the main key factors of the impairment test to evaluate the degree of sensitivity of the test to the changes in the key variables.
The Directors, also explain that the process of performing the impairment test is complex and is based on assumptions related, among others, to the expectations in term of cash flows for the subsidiaries and the determination of appropriate discount rates (WACC) and long-term growth (g-rate). Despite the Directors believe that the assumptions used are reasonable and are the most likely scenarios based on the information available, if any of the assumptions change significantly, the output of the impairment test may be different.
We considered the significance of the amount of the equity investments in Recuperator S.p.A., Hygromatik GmbH and CFM Sogutma, the subjectivity of the estimates underlying the determination of cash flows for the subsidiaries and the key variables of the impairment test. As a result we assessed that the impairment test represents a key audit matter for the audit of the Carel Industries financial statements.
Note 3 of the financial statements provides disclosure on impairment tests and the effects of sensitivity analysis resulting from the changes in the key variables used in performing the impairment test.
Finally we verified the appropriateness and the compliance of the disclosure on the impairment test to the requirements of IAS 36.
The Directors are responsible for the preparation of financial statements that give a true and fair view in accordance with International Financial Reporting Standards as adopted by the European Union and the requirements of national regulations issued pursuant to art. 9 of Italian Legislative Decree no. 38/05 and, within the terms established by law, for such internal control as the Directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless they have identified the existence of the conditions for the liquidation of the Company or for the termination of the operations or have no realistic alternative to such choices.
The Board of Statutory Auditors is responsible for overseeing, within the terms established by law, the Company's financial reporting process.


Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with International Standards on Auditing (ISA Italia) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
As part of an audit in accordance with International Standards on Auditing (ISA Italia), we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
We communicate with those charged with governance, identified at an appropriate level as required by ISA Italia, regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence applicable in Italy, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence and, where applicable, related safeguards.

5
From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors' report.
The Shareholders' Meeting of Carel Industries S.p.A. appointed us on 13 April, 2018 as auditors of the Company for the years from 31 December 2018 to 31 December 2026.
We declare that we have not provided prohibited non-audit services referred to in art. 5 (1) of EU Regulation 537/2014 and that we have remained independent of the Company in conducting the audit.
We confirm that the opinion on the financial statements expressed in this report is consistent with the additional report to the Board of Statutory Auditors, in its role of Audit Committee, referred to in art. 11 of the said Regulation.
The Directors of Carel Industries S.p.A. are responsible for the application of the provisions of the European Commission Delegated Regulation (EU) 2019/815 with regard to the regulatory technical standards on the specification of the single electronic reporting format (ESEF – European Single Electronic Format) (hereinafter referred to as the "Delegated Regulation") to the financial statements, to be included in the annual financial report.
We have carried out the procedures set forth in the Auditing Standard (SA Italia) n. 700B in order to express an opinion on the compliance of the financial statements with the provisions of the Delegated Regulation.
In our opinion, the financial statements have been prepared in XHTML format in accordance with the provisions of the Delegated Regulation.
The Directors of Carel Industries S.p.A. are responsible for the preparation of the report on operations and the report on corporate governance and ownership structure of Carel Industries S.p.A. as at 31 December 2021, including their consistency with the related financial statements and their compliance with the law.
We have carried out the procedures set forth in the Auditing Standard (SA Italia) n. 720B in order to express an opinion on the consistency of the report on operations and some specific information contained in the report on corporate governance and ownership structure set forth in art. 123-bis, n. 4 of Legislative Decree 58/98 with the financial statements of Carel Industries S.p.A. as at 31 December 2021 and on their compliance with the law, as well as to make a statement about any material misstatement.


In our opinion, the above-mentioned report on operations and information contained in the report on corporate governance and ownership structure are consistent with the financial statements of Carel Industries S.p.A. as at 31 December 2021 and are prepared in accordance with the law.
With reference to the statement referred to in art. 14, paragraph 2 (e), of Legislative Decree 39/10, made on the basis of the knowledge and understanding of the entity and of the related context acquired during the audit, we have nothing to report.
DELOITTE & TOUCHE S.p.A.
Signed by Cristiano Nacchi Partner
Padua, Italy 29 March 2022
As disclosed by the Directors on page 87, the accompanying financial statements of Carel Industries S.p.A. constitute a non-official version which is not compliant with the provisions of the Commission Delegated Regulation (EU) 2019/815.
This independent auditor's report has been translated into the English language solely for the convenience of international readers. Accordingly, only the original text in Italian language is authoritative.


| E-MARKET SDIR |
|
|---|---|
| CERTIFIED | |





| E-MARKET SDIR |
|
|---|---|
| CERTIFIED | |


| E-MARKET SDIR |
|
|---|---|
| CERTIFIED | |


| E-MARKET SDIR |
|
|---|---|
| CERTIFIED | |



CAREL INDUSTRIES HQs Via dell'Industria, 11 35020 Brugine - Padova (Italy) Tel. (+39) 0499 716611 Fax (+39) 0499 716600 [email protected]
© 2022 CAREL INDUSTRIES S.p.A. All rights reserved.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.